Neuronal Apolipoprotein E4 Expression Results in Proteome-Wide Alterations and Compromises Bioenergetic Capacity by Disrupting Mitochondrial Function
Open accessAbstract
Apolipoprotein (apo) E4, the major genetic risk factor for Alzheimer's disease (AD), alters mitochondrial function and metabolism early in AD pathogenesis. When injured or stressed, neurons increase apoE synthesis. Because of its structural difference from apoE3, apoE4 undergoes neuron-specific proteolysis, generating fragments that enter the cytosol, interact with mitochondria, and cause neurotoxicity. However, apoE4's effect on mitochondrial respiration and metabolism is not understood in detail. Here we used biochemical assays and proteomic profiling to more completely characterize the effects of apoE4 on mitochondrial function and cellular metabolism in Neuro-2a neuronal cells stably expressing apoE4 or apoE3. Under basal conditions, apoE4 impaired respiration and increased glycolysis, but when challenged or stressed, apoE4-expressing neurons had 50% less reserve capacity to generate ATP to meet energy requirements than apoE3-expressing neurons. ApoE4 expression also decreased the NAD+/NADH ratio and increased the levels of reactive oxygen species and mitochondrial calcium. Global proteomic profiling revealed widespread changes in mitochondrial processes in apoE4 cells, including reduced levels of numerous respiratory complex subunits and major disruptions to all detected subunits in complex V (ATP synthase). Also altered in apoE4 cells were levels of proteins related to mitochondrial endoplasmic reticulum-associated membranes, mitochondrial fusion/fission, mitochondrial protein translocation, proteases, and mitochondrial ribosomal proteins. ApoE4-induced bioenergetic deficits led to extensive metabolic rewiring, but despite numerous cellular adaptations, apoE4-expressing neurons remained vulnerable to metabolic stress. Our results provide insights into potential molecular targets of therapies to correct apoE4-associated mitochondrial dysfunction and altered cellular metabolism.
AI snapshot
Written from the paper’s full text.
TL;DR
In Neuro-2a cells stably expressing apoE4 versus apoE3, apoE4 impaired mitochondrial respiration and OXPHOS ATP production, increased glycolysis, and reduced spare bioenergetic capacity by about 50%. Proteomic profiling showed widespread mitochondrial and metabolic changes, including decreased respiratory complex subunits, lower NAD+/NADH, higher ROS and mitochondrial calcium, and compensatory increases in mitochondrial morphology, import, and quality-control proteins.
Key findings
- ApoE4 cells had lower basal and FCCP-stimulated respiration, OXPHOS ATP production was 33% lower, and total reserve ATP capacity was about 50% lower than apoE3 cells; basal glycolysis was increased, but maximal glycolysis was similar, and apoE4 cells showed a greater ATP deficit under stimulated respiration only.
- ApoE4 expression decreased the NAD+/NADH ratio and total NAD+ + NADH pool, increased intracellular ROS approximately twofold, and increased mitochondrial Ca2+ (about twofold after extracellular Ca2+ and nearly eightfold after thapsigargin), with faster mitochondrial Ca2+ influx.
- Label-free proteomics identified approximately 4,500 proteins; over one-third differed in apoE4 cells, including 44% of 654 MitoCarta 2.0 proteins and 42% of 953 mitochondria-associated proteins. All 33 altered OXPHOS subunits were decreased, including all 12 detected complex V subunits (some by >50%); MITRAC12 was reduced by 47% and PDH E1 subunits by 20%.
- ApoE4 cells showed increased levels of most detected MAM tethering proteins (5 of 6; GRP75 decreased), mitochondrial fusion/fission proteins, TOM/TIM import components, proteases, and all detected mitochondrial ribosomal proteins; transcription factor analyses implicated NRF1, NRF2, GABP/NRF2, E2F family members, and others.
Methods
- Mouse neuroblastoma N2a cells stably expressing full-length apoE3 or apoE4 were used for Seahorse XF96e metabolic profiling, luciferase-based ATP measurements, NAD(H) quantification, CellROX ROS flow cytometry, and live-cell Fura-2/Rhod-2 Ca2+ imaging.
- Label-free quantitative proteomics was performed on whole-cell lysates from three independent culture sets using LC-MS/MS, MaxQuant, and MSstats; pathway enrichment used DAVID, and transcription factor prediction used Pscan and PASTAA.
- Sample sizes reported: Seahorse n = 6, ATP n = 4, growth n = 3, ROS n = 3, NAD(H) n = 5, Ca2+ imaging four independent experiments with 25–40 cells per group, and proteomics three independent cultures.
Limitations
- The paper does not state limitations explicitly.
- Evident from the text: all experiments used mouse Neuro-2a cell lines stably expressing apoE3 or apoE4, not primary neurons, animal models, or human tissue, so translational relevance is uncertain.
- Evident from the text: label-free whole-cell proteomics reports steady-state protein levels and cannot establish causality or distinguish direct apoE4 effects from compensatory changes; acute Seahorse, ATP, and Ca2+ assays rely on pharmacologic modulators and defined media that may not reflect chronic in vivo conditions.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
120 of 149 cited sources checked · 62 supported · 3 flagged · accuracy not yet measured
- Premisecitation
In neurons, apoE4 is associated with decreased neurite outgrowth.
“decreased neurite outgrowth”
Quote in the paperNot a substantial claim6 of 6 sources checked- cites [10] Mahley, 2006, Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer’s disease, Proc Natl Acad Sci U S A source
- cites [17] Chang, 2005, Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity, Proc Natl Acad Sci U S A source
The Results report greater cell death from an apoE4 fragment in Neuro-2a cells, but do not report decreased neurite outgrowth. Searches for “neurite outgrowth” and “neurite extension” found no passage in our copy addressing that outcome. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [18] Chen, 2011, Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease, J Biol Chem source
The section on mitochondrial respiratory complexes in neuronal cells reports lower levels of those complexes in apoE4-expressing neurons, but does not assess neurite outgrowth. Searches for “neurite outgrowth” and “neurite extension and neuronal process growth” found no passage addressing the claimed outcome. Page numbers were not available in our copy. (LLM, conf=0.73)
Experimental — accuracy not yet measured - cites [19] Chen, 2012, Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons, J Biol Chem source
- cites [34] Brodbeck, 2008, Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons, Proc Natl Acad Sci U S A source
The Results report that apoE4 reduced dendritic spine density in primary cortical neurons compared with apoE3. The introduction mentions neurite outgrowth, but our copy does not clearly state that apoE4 decreases it; spine density and neurite outgrowth are distinct measures. No page number is available in the indexed passages. (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites [35] Brodbeck, 2011, Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctors, J Biol Chem source
- Premisecitation
ApoE fragments escape the secretory pathway into the cytosol.
“The resulting apoE fragments escape the secretory pathway into the cytosol”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [17] Chang, 2005, Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity, Proc Natl Acad Sci U S A source
- cites [18] Chen, 2011, Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease, J Biol Chem source
The Discussion (page not provided) says neuronal apoE can be cleaved into fragments and that an apoE4 fragment mislocalized to mitochondria when expressed in N2A cells. It does not say the fragments escape the secretory pathway into the cytosol; it describes mitochondrial targeting of proteolytic fragments in this study as a possibility, not an established route. (LLM, conf=0.81)
Experimental — accuracy not yet measured - cites [19] Chen, 2012, Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons, J Biol Chem source
The Discussion (page not available) mentions neuron-specific proteolysis and neurotoxic apoE4 fragment formation. Neither that passage nor passages retrieved for “cytosol” and “secretory pathway” say that apoE fragments leave the secretory pathway or enter the cytosol. (LLM, conf=0.74)
Experimental — accuracy not yet measured
- Premisecitation
In neurons, apoE4 is associated with impaired mitochondrial respiration.
“In neurons, apoE4 is associated with impaired mitochondrial respiration”
Quote in the paperSubstantial claim6 of 6 sources checked- cites [10] Mahley, 2006, Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer’s disease, Proc Natl Acad Sci U S A source
The section “ApoE4 Neuropathology Independent of Aβ” (page unavailable) associates apoE4 with reduced neuronal glucose utilization and describes mitochondrial dysfunction in cultured neurons. That supports impaired mitochondrial function, but the paper does not specifically establish impaired mitochondrial respiration. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [17] Chang, 2005, Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity, Proc Natl Acad Sci U S A source
The Results report impaired mitochondrial function in Neuro-2a cells expressing truncated apoE4 fragments, measured by MitoTracker fluorescence. They do not report a direct measure of mitochondrial respiration, and the effect was observed with fragments rather than full-length apoE4. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [18] Chen, 2011, Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease, J Biol Chem source
- cites [19] Chen, 2012, Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons, J Biol Chem source
- cites [34] Brodbeck, 2008, Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons, Proc Natl Acad Sci U S A source
The introduction (page unavailable) says that apoE4 fragments in neurons impair mitochondrial membrane potential and function, and the Results likewise describe impaired mitochondrial function. The copy does not specifically identify impaired mitochondrial respiration, so it supports the broader association but not that particular measure. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [35] Brodbeck, 2011, Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctors, J Biol Chem source
The Abstract and the section on apoE4 trafficking in mouse primary hippocampal neurons report impaired intracellular trafficking, not mitochondrial respiration. Searches for mitochondrial respiration and oxygen consumption found no passage in our copy addressing the claimed respiratory impairment. (LLM, conf=0.75)
Experimental — accuracy not yet measured
- Premisecitation
In neurons, apoE4 is associated with neurotoxicity.
“and neurotoxicity [10, 17–19, 34, 35]”
Quote in the paperSubstantial claim6 of 6 sources checked- cites [10] Mahley, 2006, Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer’s disease, Proc Natl Acad Sci U S A source
- cites [17] Chang, 2005, Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity, Proc Natl Acad Sci U S A source
- cites [18] Chen, 2011, Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease, J Biol Chem source
- cites [19] Chen, 2012, Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons, J Biol Chem source
- cites [34] Brodbeck, 2008, Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons, Proc Natl Acad Sci U S A source
- cites [35] Brodbeck, 2011, Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctors, J Biol Chem source
- Premisecitation
The largest apoE4 fragment, apoE4(1-272), causes mitochondrial fragmentation.
“and cause mitochondrial fragmentation [10, 17, 20]”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [10] Mahley, 2006, Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer’s disease, Proc Natl Acad Sci U S A source
In “ApoE4 Neuropathology Independent of Aβ” (page unavailable), the paper says apoE4(1-272) accumulates in mitochondria and describes mitochondrial dysfunction associated with apoE fragments. It does not say that apoE4(1-272) causes mitochondrial fragmentation, a distinct change in mitochondrial structure. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [17] Chang, 2005, Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity, Proc Natl Acad Sci U S A source
The Results report that apoE4(1-272) interacted with mitochondria in Neuro-2a cells and reduced MitoTracker fluorescence, which the authors interpret as impaired mitochondrial function and integrity. They do not report mitochondrial fragmentation; the filamentous inclusions described in the Results concern the apoE4 fragment, not mitochondrial shape. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [20] Nakamura, 2009, Apolipoprotein E4 (1–272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells, Mol Neurodegener source
The Conclusion (page unavailable) reports that apoE4(1–272) expression in Neuro2a cells reduced the activities of mitochondrial respiratory complexes III and IV. This supports an effect on mitochondrial function, but the copy does not report mitochondrial fragmentation; searches for fragmentation and mitochondrial morphology found no such result. (LLM, conf=0.83)
Experimental — accuracy not yet measured
- Premisecitation
Young, cognitively normal apoE4 carriers have glucose hypometabolism in brain regions affected by Alzheimer's disease.
“Young, cognitively normal apoE4 carriers have glucose hypometabolism in brain regions affected by AD [29–31]”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [29] Reiman, 1996, Preclinical evidence of Alzheimer’s disease in persons homozygous for the ɛ4 allele for apolipoprotein E, N Engl J Med source
The Abstract reports reduced glucose metabolism in Alzheimer’s-affected brain regions among cognitively normal ε4 homozygotes. But its Methods specify volunteers aged 50–65, and Figure 2 gives a mean age of 55; this does not establish the claim for young carriers or for carriers generally. Page numbers are not supplied in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [30] Small, 2000, Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer’s disease, Proc Natl Acad Sci U S A source
The Results report lower glucose metabolism in the inferior parietal, lateral temporal, and posterior cingulate regions of nondemented APOE-4 carriers. The Methods give an age range of 50–84 years, and the Results give carriers a mean age of 65.9 years; this does not support describing the studied group as young. Their memory scores were within age norms, although many had age-associated memory impairment or mild cognitive impairment. Page numbers are unavailable in our copy. (LLM, conf=0.90)
Experimental — accuracy not yet measured - cites [31] Reiman, 2004, Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer’s dementia, Proc Natl Acad Sci U S A source
- Premisecitation
ApoE4 impairs respiratory function in Neuro-2a cells.
“and impairs respiratory function [18]”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [18] Chen, 2011, Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease, J Biol Chem source
- Premisecitation
In nondemented apoE4 carriers, mitochondrial complex IV activity is decreased in cortical regions susceptible to Alzheimer's disease.
“in nondemented apoE4 carriers, the activity of mitochondrial complex IV is decreased in cortical regions susceptible to AD [32]”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [32] Valla, 2010, Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE ɛ4 allele, the major late-onset Alzheimer’s susceptibility gene, J Alzheimers Dis source
The Results report significantly lower cytochrome oxidase (mitochondrial complex IV) activity in young-adult APOE ε4 carriers than in noncarriers, but the measurements were from the posterior cingulate cortex. The Discussion says further studies are needed to determine whether the reduction extends beyond that region, so the claim's plural “cortical regions” is broader than this study establishes. Page numbers are unavailable in our copy. (LLM, conf=0.89)
Experimental — accuracy not yet measured
- Premisecitation
The single amino acid difference increases apoE4 cleavage by a stress-induced neuron-specific protease.
“increases its cleavage by a stress-induced neuron-specific protease [7, 12, 16]”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [7] Huang, 2012, Alzheimer mechanisms and therapeutic strategies, Cell source
In the ApoE4 section (page unavailable), the paper says apoE isoforms differ by single amino acid substitutions and neuronal apoE4 is more susceptible to cleavage than apoE3. It says stress or injury induces neuronal apoE expression, not that the protease is stress-induced; it reports cleavage in neurons but does not establish that the protease itself is neuron-specific. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [12] Mahley, 2012, Apolipoprotein E sets the stage: Response to injury triggers neuropathology, Neuron source
The ‘ApoE Hypothesis’ section says structural differences make apoE4 more susceptible to neuronal proteolytic cleavage than apoE3 or apoE2. The ‘Neuron-Specific Proteolysis’ section describes the responsible protease as unidentified. The paper says injury or stress induces neuronal apoE synthesis, not that it induces the protease. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [16] Huang, 2001, Apolipoprotein E fragments present in Alzheimer’s disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons, Proc Natl Acad Sci U S A source
- Premisecitation
ApoE4 increases risk for Alzheimer's disease.
“ApoE4 increases risk for AD”
Quote in the paperSubstantial claim9 of 10 sources checked- cites [4] Biundo, 2015, Interaction of apoE3 and apoE4 isoforms with an ITM2b/BRI2 mutation linked to the Alzheimer disease-like Danish dementia: Effects on learning and memory, Neurobiol Learn Mem source
- cites [5] Bu, 2009, Apolipoprotein E and its receptors in Alzheimer’s disease: Pathways, pathogenesis and therapy, Nat Rev Neurosci source
- cites [6] Holtzman, 2012, Apolipoprotein E and apolipoprotein E receptors: Normal biology and roles in Alzheimer disease, Cold Spring Harb Perspect Med source
- cites [7] Huang, 2012, Alzheimer mechanisms and therapeutic strategies, Cell source
- cites [8] Kim, 2009, The role of apolipoprotein E in Alzheimer’s disease, Neuron source
- cites [9] Liu, 2013, Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy, Nat Rev Neurol source
- cites [10] Mahley, 2006, Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer’s disease, Proc Natl Acad Sci U S A source
- cites [11] Mahley, 2009, Apolipoprotein E: Structure determines function, from atherosclerosis to Alzheimer’s disease to AIDS, J Lipid Res source
- cites [12] Mahley, 2012, Apolipoprotein E sets the stage: Response to injury triggers neuropathology, Neuron source
- cites [13] Mahley, 2012, Small-molecule structure correctors target abnormal protein structure and function: The structure corrector rescue of apolipoprotein E–associated neuropathology, J Med Chem source
- Premisecitation
Mice expressing human apoE4 show deficient uptake and metabolism of glucose in the brain.
“Mice expressing human apoE4 show deficient uptake and metabolism of glucose in the brain [33].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [33] Wu, 2018, Human apoE isoforms differentially modulate brain glucose and ketone body metabolism: Implications for Alzheimer’s disease risk reduction and early intervention, J Neurosci source
- Premisecitation
Expression of apoE4 fragments containing the lipid-binding domain in N2a cells results in neurotoxicity.
“expression of fragments containing this domain in N2a cells results in neurotoxicity [17]”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [17] Chang, 2005, Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity, Proc Natl Acad Sci U S A source
The Results report that expressing apoE4(1–272), which contains the lipid-binding region, caused greater cell death in Neuro-2a cells. But the Results also state that the lipid-binding region alone caused no neurotoxicity: the receptor-binding region was required too. The claim omits that qualification. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
The interaction of apoE4 fragments with mitochondria is dependent on the apoE lipid-binding domain.
“The interaction of apoE4 fragments with mitochondria is dependent on the apoE lipid-binding domain”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [17] Chang, 2005, Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity, Proc Natl Acad Sci U S A source
- Premisecitation
ApoE4 reduces the level of respiratory chain subunits in Neuro-2a cells.
“ApoE4 also reduces the level of respiratory chain subunits in Neuro-2a (N2a) cells”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [18] Chen, 2011, Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease, J Biol Chem source
- Premisecitation
Expression of apoE4 in mouse neurons, but not astrocytes, selectively decreases the expression of mitochondrial respiratory subunits.
“Expression of apoE4 in mouse neurons, but not astrocytes, selectively decreases the expression of mitochondrial respiratory subunits [18].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [18] Chen, 2011, Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease, J Biol Chem source
- Interpretationcitation
Impaired PDH activity might be partly responsible for the respiratory deficits in apoE4 cells.
“Since PDH deficiency limits respiratory capacity and causes lactic acidosis in humans [92], impaired PDH activity might be partly responsible for the respiratory deficits in apoE4 cells.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [92] Fluge, 2016, Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome, JCI Insight source
- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Findingown data
Using MitoMiner 4.0 and the Gene Ontology "Mitochondrion" category, 953 proteins associated with mitochondria were identified.
“Using the MitoMiner 4.0 database [73] and the Gene Ontology “Mitochondrion” category [74, 75], we identified 953 proteins associated with mitochondria; the levels of 42% of those proteins were significantly changed by apoE4 expression, again with equal numbers increased and decreased (Fig. 5A).”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [73] Smith, 2016, MitoMiner v3.1, an update on the mitochondrial proteomics database, Nucleic Acids Res source
The Introduction identifies MitoMiner as a database for investigating mitochondrial proteins and says it incorporates Gene Ontology annotations. But this paper describes MitoMiner v3.1, not the cited version 4.0. The 953-protein count is presented as the citing authors’ own result, not a finding attributed to this source. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [74] Ashburner, 2000, Gene Ontology: Tool for the unification of biology, Nat Genet source
- cites [75] The Gene Ontology Consortium, 2017, Expansion of the Gene Ontology knowledgebase and resources, Nucleic Acids Res source
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
- Findingown data
Pscan and PASTAA identified transcription factors that may coordinate the changes in protein levels in apoE4-expressing cells.
“To determine which regulatory pathways help compensate for apoE4-induced mitochondrial dysfunction, we used Pscan [64] and PASTAA [63] to identify transcription factors that may coordinate the changes in protein levels in apoE4-expressing cells (Table 1).”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [64] Zambelli, 2009, Pscan: Finding over-represented transcription factor binding site motifs in sequences from co-regulated or co-expressed genes, Nucleic Acids Res source
- cites [63] Roider, 2009, PASTAA: Identifying transcription factors associated with sets of co-regulated genes, Bioinformatics source
- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
- Premisecitation
Previously, the authors showed that apoE4 decreases levels of cytochrome c oxidase 1 (COX1).
“Previously we showed that apoE4 decreases levels of cytochrome c oxidase 1 (COX1) [18], a mitochondrially encoded subunit that initiates complex IV assembly [82].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [18] Chen, 2011, Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease, J Biol Chem source
- Premisecitation
Several of the transcription factors identified are implicated in neurodegeneration, including nuclear respiratory factor 1, nuclear factor erythroid-2-like 2, ETS domain-containing protein Elk-1, Kruppel-like factor 14, and Sp4.
“Additionally, several of the transcription factors identified are implicated in neurodegeneration, including nuclear respiratory factor 1 [117, 118], nuclear factor erythroid-2-like 2 [110, 111], ETS domain-containing protein Elk-1 [119], Kruppel-like factor 14 [120], and Sp4 [121].”
Quote in the paperNot a substantial claim4 of 5 sources checked- cites [117] Taherzadeh-Fard, 2011, PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease, Mol Neurodegener source
- cites [118] Urfer-Buchwalder, 2017, Identification of a nuclear respiratory factor 1 recognition motif in the apolipoprotein E variant APOE4 linked to Alzheimer’s disease, Sci Rep source
- cites [110] Scarpulla, 2005, Nuclear control of respiratory gene expression in mammalian cells, J Cell Biochem source
- cites [111] Ohtsuji, 2008, Nrf1 and Nrf2 play distinct roles in activation of antioxidant response element-dependent genes, J Biol Chem source
The Abstract and Discussion describe Nrf1 and Nrf2 in antioxidant-gene regulation and mouse liver pathology, but the passages do not link either factor to neurodegeneration. A search for neurodegenerative disease and neuronal terms found no passage establishing that link. The paper’s CNC-family Nrf1 should also not be assumed to mean nuclear respiratory factor 1. (LLM, conf=0.75)
Experimental — accuracy not yet measured - cites [119] Besnard, 2011, Elk-1 a transcription factor with multiple facets in the brain, Front Neurosci source
- Premisecitation
ApoE4 also affects respiratory complex formation.
“In concert with mitochondrial proteases, which respond to altered mitochondrial protein stoichiometry [107], apoE4 also affects respiratory complex formation [108].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [108] Friedman, 2015, MICOS coordinates with respiratory complexes and lipids to establish mitochondrial inner membrane architecture, eLife source
The Results and Discussion passages address MICOS, respiratory complexes, and mitochondrial architecture, but do not address apoE4. Searches for “apoE4,” “apolipoprotein E4,” and its effect on respiratory complex formation found no supporting passage in our copy. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Premisecitation
Increased ER-mitochondrial interactions increase MAM activity in neurons treated with conditioned medium from apoE4- but not apoE3-expressing astrocytes.
“Increased ER-mitochondrial interactions increase MAM activity in neurons treated with conditioned medium from apoE4- but not apoE3-expressing astrocytes [104].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [104] Tambini, 2016, ApoE4 upregulates the activity of mitochondria-associated ER membranes, EMBO Rep source
The Results and Discussion report increased phosphatidylethanolamine synthesis in mouse hippocampal neurons treated with ApoE4 versus ApoE3 astrocyte-conditioned medium, supporting increased MAM-related activity. They do not show that increased physical ER–mitochondrial interactions caused that neuronal effect; the paper says the mechanism is unclear, and its apposition measurement showed only a trend in ApoE4-treated cells. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Findingown data
Global proteomic profiling revealed widespread changes in mitochondrial processes in apoE4 cells.
“Global proteomic profiling revealed widespread changes in mitochondrial processes in apoE4 cells”
Quote in the paperSubstantial claim - Findingown data
Glycolysis was enhanced in apoE4 cells under basal conditions.
“Glycolysis was enhanced in apoE4 cells under basal conditions; however, the glycolytic rate and ATP production were insufficient to maintain total cellular energy under conditions of high metabolic demand.”
Quote in the paperSubstantial claim - Findingown data
Under maximal stress stimulation, apoE4-expressing neurons lacked spare capacity to generate significant ATP levels by OXPHOS and glycolysis.
“apoE4-expressing neurons, unlike those expressing apoE3, lacked spare capacity to generate significant ATP levels by OXPHOS and glycolysis (Fig. 1D)”
Quote in the paperSubstantial claim - Findingown data
ApoE4 cells had altered levels of proteins related to proteases.
“proteases”
Quote in the paperNot a substantial claim - Findingown data
The rate of Ca2+ influx into mitochondria in response to extracellular Ca2+ was much greater in apoE4-expressing cells than in apoE3-expressing cells.
“In contrast, in response to extracellular Ca2+, both the basal mitochondrial Ca2+ level (Fig. 4E) and the rate of Ca2+ influx into mitochondria in response to extracellular Ca2+ were much greater in cells expressing apoE4 (Fig. 4F, H), culminating in twofold higher levels of mitochondrial Ca2+ (Fig. 4G).”
Quote in the paperSubstantial claim - Findingown data
Maximal glycolysis rate was similar in apoE3- and apoE4-expressing cells when glycolysis was stimulated by monensin and respiration was inhibited by antimycin A.
“the maximal glycolysis rate was similar in apoE3- and apoE4-expressing cells when glycolysis was stimulated by monensin and respiration was inhibited by antimycin A”
Quote in the paperSubstantial claim - Findingown data
ApoE4 expression increased mitochondrial calcium levels.
“and mitochondrial calcium”
Quote in the paperNot a substantial claim - Findingown data
The total NAD+ + NADH pool was smaller in apoE4-expressing cells than in apoE3-expressing cells.
“Interestingly, the total NAD+ + NADH pool was smaller in the apoE4 cells, suggesting that apoE4 impairs NAD+ synthetic capacity [68].”
Quote in the paperSubstantial claim - Findingown data
ApoE4 altered a wide range of proteins involved in OXPHOS, redox homeostasis, and glucose and amino acid metabolism.
“ApoE4 altered a wide range of proteins involved in OXPHOS, redox homeostasis, and glucose and amino acid metabolism (Fig. 6).”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
- Findingown data
ApoE4 cells had altered levels of proteins related to mitochondrial ribosomal proteins.
“and mitochondrial ribosomal proteins”
Quote in the paperNot a substantial claim - Findingown data
ApoE4 cells had altered levels of proteins related to mitochondrial protein translocation.
“mitochondrial protein translocation”
Quote in the paperSubstantial claim - Findingown data
Combined total ATP production rates under basal conditions were similar in apoE3 and apoE4 cells.
“The combined total ATP production rates under basal conditions were similar.”
Quote in the paperSubstantial claim - Findingown data
Volcano plots confirmed that there were both significantly higher and significantly lower levels of subsets of mitochondrial proteins in apoE4-expressing cells.
“Volcano plots of –log10 (adjusted p-value) significance levels versus fold change in protein levels confirmed that there were both significantly higher and significantly lower levels of subsets of mitochondrial proteins in the apoE4-expressing cells (Fig. 5B).”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
- Findingown data
ApoE4 decreased the levels of 33 of 64 detected subunits.
“Our proteomic analysis showed that apoE4 decreased the levels of 33 of 64 detected subunits, undoubtedly altering complex assembly.”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
- Findingown data
Cytosolic Ca2+ influx after thapsigargin treatment was not significantly lower in apoE4 than in apoE3 cells.
“Cytosolic Ca2+ influx after treatment with thapsigargin was not significantly lower in apoE4 than apoE3 cells (Fig. 4I, J), but mitochondrial Ca2+ influx was significantly greater in apoE4 cells (Fig. 4K), resulting in nearly eightfold higher levels (Fig. 4L).”
Quote in the paperSubstantial claim - Findingown data
Under basal conditions, apoE4 increased glycolysis in N2a cells.
“Under basal conditions, apoE4 impaired respiration and increased glycolysis”
- Also stated in: § ApoE4 expression alters the bioenergetics profile in neuronal cells · plain
“apoE4-expressing cells shift to glycolysis to meet energy demands under basal conditions (Fig. 1B)”
Quote in the paperSubstantial claim - Also stated in: § ApoE4 expression alters the bioenergetics profile in neuronal cells · plain
- Findingown data
ApoE4 expression increased the levels of reactive oxygen species.
“increased the levels of reactive oxygen species”
Quote in the paperSubstantial claim - Findingown data
MITRAC12, a central component of the MITRAC assembly complex, was reduced by 47% in apoE4-expressing cells (p < 1×10-9).
“For example, complex IV assembly requires the MITRAC assembly complex, a central component of which, MITRAC12, was reduced by 47% in apoE4-expressing cells (p < 1×10–9).”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
- Rests on an assumption: Complex IV assembly requires the MITRAC assembly complex.
- Findingown data
TIGAR was also decreased significantly in apoE4-expressing cells.
“Interestingly, TIGAR, an enzyme that negatively regulates glycolytic activity [88, 89], was also decreased significantly, perhaps to enhance glycolytic activity in the context of mitochondrial dysfunction and reduced levels of glycolytic enzymes.”
Quote in the paperNot a substantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
- Findingown data
ATP production rates by OXPHOS in apoE4 cells were 33% lower than in apoE3 cells.
“ATP production rates by OXPHOS in apoE4 cells were 33% lower”
Quote in the paperSubstantial claim - Findingown data
NAD+ was significantly lower in apoE4-expressing cells than in apoE3-expressing cells.
“We found that NADH was significantly higher, and NAD+ was significantly lower, in apoE4-expressing cells, resulting in a lower NAD+/NADH ratio (Fig. 3A).”
Quote in the paperSubstantial claim - Findingown data
ApoE4 cells had major disruptions to all detected subunits in complex V (ATP synthase).
“and major disruptions to all detected subunits in complex V (ATP synthase)”
Quote in the paperSubstantial claim - Findingown data
In response to extracellular Ca2+, the basal mitochondrial Ca2+ level was much greater in apoE4-expressing cells than in apoE3-expressing cells.
“In contrast, in response to extracellular Ca2+, both the basal mitochondrial Ca2+ level (Fig. 4E) and the rate of Ca2+ influx into mitochondria in response to extracellular Ca2+ were much greater in cells expressing apoE4 (Fig. 4F, H), culminating in twofold higher levels of mitochondrial Ca2+ (Fig. 4G).”
Quote in the paperSubstantial claim - Findingown data
ATP production rates by glycolysis in apoE4 cells were increased to a greater extent than in apoE3 cells.
“were increased to a greater extent by glycolysis than in apoE3 cells (Fig. 1C)”
Quote in the paperSubstantial claim - Findingown data
ApoE4-expressing neurons display a coordinated decrease in respiratory chain subunits.
“and a coordinated decrease in respiratory chain subunits”
Quote in the paperSubstantial claim - Findingown data
ApoE4-expressing cells had significantly lower rates of basal and FCCP-stimulated respiration than apoE3-expressing cells.
“apoE4-expressing neuronal cells had significantly lower rates of basal and FCCP-stimulated respiration than apoE3-expressing cells (Fig. 1A)”
Quote in the paperSubstantial claim - Findingown data
Mitochondrial Ca2+ levels 6 min after thapsigargin treatment were nearly eightfold higher in apoE4 cells than in apoE3 cells.
“Cytosolic Ca2+ influx after treatment with thapsigargin was not significantly lower in apoE4 than apoE3 cells (Fig. 4I, J), but mitochondrial Ca2+ influx was significantly greater in apoE4 cells (Fig. 4K), resulting in nearly eightfold higher levels (Fig. 4L).”
Quote in the paperSubstantial claim - Findingown data
ApoE4 cells had altered levels of proteins related to mitochondrial fusion/fission.
“mitochondrial fusion/fission”
Quote in the paperNot a substantial claim - Findingown data
ApoE4-expressing neurons display impaired mitochondrial energy production.
“ApoE4-expressing neurons display impaired mitochondrial energy production”
Quote in the paperSubstantial claim - Findingown data
There were alterations in a wide range of proteins involved in glycolysis, redox regulation, intermediary metabolism, mitochondrial morphology, and the import, synthesis, and degradation of mitochondrial proteins.
“There were also alterations in a wide range of proteins involved in glycolysis, redox regulation, and intermediary metabolism; in mitochondrial morphology; and in the import, synthesis, and degradation of mitochondrial proteins.”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
- Findingown data
Basal cytosolic Ca2+ levels did not differ between apoE3- and apoE4-expressing cells.
“The two cell lines did not differ in basal cytosolic Ca2+ levels (Fig. 4A) or in overall Ca2+ influx induced by extracellular Ca2+ (Fig. 4B).”
Quote in the paperNot a substantial claim - Findingown data
Label-free quantitative proteomic profiling of whole-cell lysates from N2a-apoE3 and N2a-apoE4 cells by LC-MS/MS identified approximately 4500 distinct proteins.
“Label-free, quantitative proteomic profiling of whole-cell lysates from N2a-apoE3 and N2a-apoE4 cells by LC-MS/MS identified approximately 4500 distinct proteins (Fig. 5A).”
Quote in the paperSubstantial claim- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
- Findingown data
COX7a is significantly decreased in apoE4-expressing neurons.
“For example, COX7a has a critical role in stabilizing complexes III and IV [39] and is significantly decreased in apoE4-expressing neurons.”
Quote in the paperNot a substantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
- Findingown data
ApoE4-expressing cells shift to glycolysis to meet energy demands under basal conditions.
“apoE4-expressing cells shift to glycolysis to meet energy demands under basal conditions (Fig. 1B)”
Quote in the paperSubstantial claim - Findingown data
Under conditions that prevent net ATP production by glycolysis (basal respiration only), apoE4-expressing cells maintained total ATP levels during the 1-h challenge.
“Surprisingly, under conditions that prevent net ATP production by glycolysis (basal respiration only) [65], apoE4-expressing cells maintained total ATP levels during the 1-h challenge, possibly by decreasing energy utilization or increasing reliance on glycogen stores.”
Quote in the paperNot a substantial claim - Findingown data
The NAD+/NADH ratio was lower in apoE4-expressing cells than in apoE3-expressing cells.
“We found that NADH was significantly higher, and NAD+ was significantly lower, in apoE4-expressing cells, resulting in a lower NAD+/NADH ratio (Fig. 3A).”
Quote in the paperSubstantial claim - Findingown data
Many other mitochondrial matrix enzymes, including those involved in the tricarboxylic acid cycle and in amino acid and ketone body metabolism, were significantly increased in apoE4-expressing cells.
“In contrast, many other mitochondrial matrix enzymes, including those involved in the tricarboxylic acid cycle and in amino acid and ketone body metabolism, were significantly increased in apoE4-expressing cells (Fig. 6).”
Quote in the paperNot a substantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
- Findingown data
ApoE4-expressing cells were more reliant on glycolysis under basal conditions than apoE3 cells.
“apoE4-expressing cells were more reliant on glycolysis under basal conditions than apoE3 cells”
Quote in the paperSubstantial claim - Findingown data
Both analyses highlighted transcription factors that regulate the expression of mitochondrial genes and genes related to metabolism and redox homeostasis.
“Both analyses highlighted transcription factors that regulate the expression of mitochondrial genes and genes related to metabolism and redox homeostasis.”
Quote in the paperNot a substantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
- Findingown data
Glycolytic ATP production by apoE3- and apoE4-expressing cells increased to comparable levels when mitochondrial ATP synthesis was blocked with oligomycin or when respiration was inhibited with antimycin A and monensin.
“glycolytic ATP production by apoE3- and apoE4-expressing cells increased to comparable levels when mitochondrial ATP synthesis was blocked with oligomycin or when respiration was inhibited with antimycin A and monensin”
Quote in the paperSubstantial claim - Findingown data
Overall Ca2+ influx induced by extracellular Ca2+ did not differ between apoE3- and apoE4-expressing cells.
“The two cell lines did not differ in basal cytosolic Ca2+ levels (Fig. 4A) or in overall Ca2+ influx induced by extracellular Ca2+ (Fig. 4B).”
Quote in the paperNot a substantial claim - Findingown data
Gene Ontology and KEGG pathway-enrichment analyses revealed a diverse array of effects of apoE4 on cellular processes.
“These analyses revealed a diverse array of effects of apoE4 on cellular processes.”
Quote in the paperNot a substantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
- Findingown data
When stressed with FCCP, ATP production by OXPHOS in apoE4-expressing cells was markedly lower than in apoE3-expressing cells.
“but ATP production by OXPHOS was markedly lower”
Quote in the paperSubstantial claim - Findingown data
The changes in apoE4-expressing neurons are associated with altered calcium handling (increased mitochondrial calcium).
“altered calcium handling (increased mitochondrial calcium)”
Quote in the paperSubstantial claim - Findingown data
ApoE4 cells showed increases in many other mitochondrial components, including proteins involved in mitochondrial morphology, protein import, protein maturation and degradation, and mitochondrial protein synthesis.
“We also detected increases in many other mitochondrial components in apoE4 cells, including proteins involved in mitochondrial morphology (fusion/fission; cristae formation), protein import (TOM/TIM complexes and assembly), protein maturation and degradation (proteases), and mitochondrial protein synthesis (ribosomal subunits) (Fig. 9).”
Quote in the paperNot a substantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
- Findingown data
Mitochondrial processes and pathways were identified from the sets of proteins increased or decreased by apoE4.
“Interestingly, mitochondrial processes and pathways were identified from the sets of proteins increased or decreased by apoE4.”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
- Findingown data
ApoE4 cells had altered levels of proteins related to mitochondrial endoplasmic reticulum-associated membranes.
“Also altered in apoE4 cells were levels of proteins related to mitochondrial endoplasmic reticulum–associated membranes”
Quote in the paperNot a substantial claim - Findingown data
Total reserve capacity was about 50% lower in apoE4-expressing cells.
“the total reserve capacity was about 50% lower in apoE4-expressing cells”
Quote in the paperSubstantial claim - Findingown data
Mitochondrial Ca2+ influx after thapsigargin treatment was significantly greater in apoE4 cells than in apoE3 cells.
“Cytosolic Ca2+ influx after treatment with thapsigargin was not significantly lower in apoE4 than apoE3 cells (Fig. 4I, J), but mitochondrial Ca2+ influx was significantly greater in apoE4 cells (Fig. 4K), resulting in nearly eightfold higher levels (Fig. 4L).”
Quote in the paperSubstantial claim - Findingown data
Under basal conditions, apoE4 impaired respiration in N2a cells.
“Under basal conditions, apoE4 impaired respiration and increased glycolysis”
- Also stated in: § ApoE4 expression alters the bioenergetics profile in neuronal cells · plain
“apoE4-expressing neuronal cells had significantly lower rates of basal and FCCP-stimulated respiration than apoE3-expressing cells (Fig. 1A)”
Quote in the paperSubstantial claim - Also stated in: § ApoE4 expression alters the bioenergetics profile in neuronal cells · plain
- Findingown data
ApoE4 expression decreased the NAD+/NADH ratio.
“ApoE4 expression also decreased the NAD+/NADH ratio”
Quote in the paperSubstantial claim - Findingown data
Under conditions that increase ATP demand by glycolysis and impair mitochondrial ATP production (stimulated glycolysis only), apoE3- and apoE4-expressing cells showed a similar partial loss of cellular ATP production.
“Under conditions that increase ATP demand by glycolysis and impair mitochondrial ATP production (stimulated glycolysis only), apoE3- and apoE4-expressing cells showed a similar partial loss of cellular ATP production.”
Quote in the paperNot a substantial claim - Findingown data
ApoE4 cells had reduced levels of numerous respiratory complex subunits.
“including reduced levels of numerous respiratory complex subunits”
Quote in the paperSubstantial claim - Findingown data
NADH was significantly higher in apoE4-expressing cells than in apoE3-expressing cells.
“We found that NADH was significantly higher, and NAD+ was significantly lower, in apoE4-expressing cells, resulting in a lower NAD+/NADH ratio (Fig. 3A).”
Quote in the paperSubstantial claim - Findingown data
The changes in apoE4-expressing neurons are associated with increased ROS production.
“increased ROS production”
Quote in the paperSubstantial claim - Findingown data
The changes in apoE4-expressing neurons are countered by increased levels of subsets of other mitochondrial proteins involved in mitochondrial morphology, protein transport, and protein degradation.
“are countered by increased levels of subsets of other mitochondrial proteins involved in mitochondrial morphology, protein transport, and protein degradation”
Quote in the paperSubstantial claim - Findingown data
The levels of all glycolytic enzymes in apoE4-expressing cells that differed from the levels in apoE3-expressing cells were lower in the apoE4 cells.
“For example, the levels of all glycolytic enzymes in apoE4-expressing cells that differed from the levels in apoE3-expressing cells were lower in the apoE4 cells.”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
- Findingown data
Intracellular ROS levels determined by CellROX assay were approximately twofold higher in apoE4-expressing cells than in apoE3-expressing cells.
“Intracellular ROS levels determined by CellROX assay were approximately twofold higher in apoE4-expressing cells (Fig. 3B).”
Quote in the paperSubstantial claim - Findingown data
When stressed with FCCP, ATP production by glycolysis in apoE4-expressing cells was similar to that in apoE3-expressing cells.
“when cells were stressed with FCCP, ATP production by glycolysis in apoE4-expressing cells was similar to that in apoE3-expressing cells”
Quote in the paperSubstantial claim - Findingown data
The levels of both E1 subunits of PDH in apoE4 cells were reduced by 20%.
“Indeed, levels of both E1 subunits of PDH in apoE4 cells were reduced by 20%.”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
- Findingown data
When challenged or stressed, apoE4-expressing neurons had 50% less reserve capacity to generate ATP to meet energy requirements than apoE3-expressing neurons.
“when challenged or stressed, apoE4-expressing neurons had 50% less reserve capacity to generate ATP to meet energy requirements than apoE3-expressing neurons”
Quote in the paperSubstantial claim - Findingown data
Mitochondrial respiration and OXPHOS-dependent ATP production are impaired in apoE4-expressing cells, being 40-50% lower than in apoE3-expressing cells.
“We found that mitochondrial respiration and OXPHOS-dependent ATP production are impaired in apoE4-expressing cells, being 40–50% lower than in apoE3-expressing cells.”
Quote in the paperSubstantial claim - Findingown data
The changes in apoE4-expressing neurons are associated with a lower NAD+/NADH ratio.
“These changes are associated with a lower NAD+/NADH ratio”
Quote in the paperSubstantial claim - Findingown data
ApoE4 expression altered the mitochondrial cristae-organizing system.
“ApoE4 expression also altered the mitochondrial cristae–organizing system, which stabilizes the cristae junction between the inner and outer membranes.”
Quote in the paperNot a substantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
- Findingown data
The levels of four major proteins directly involved in mitochondrial dynamics were significantly increased by apoE4 expression.
“Levels of four major proteins directly involved in mitochondrial dynamics were significantly increased by apoE4 expression, as shown by proteomics analyses.”
Quote in the paperNot a substantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
- Findingown data
Unbiased analyses to predict which transcription factors might control the proteomic changes in apoE4 cells identified a surprising number of factors known to influence mitochondrial biogenesis and regulate the expression of additional metabolism- and redox-related genes.
“Our unbiased analyses to predict which transcription factors might control the proteomic changes in apoE4 cells identified a surprising number of factors known to influence mitochondrial biogenesis and regulate the expression of additional metabolism- and redox-related genes.”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
- Findingown data
The levels of all of these MAM proteins except GRP75 were significantly increased in apoE4 cells.
“Remarkably, levels of all of these MAM proteins except GRP75 were significantly increased in the apoE4 cells (Fig. 8).”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
- Findingown data
The levels of all mitochondrial ribosomal proteins detected by proteomics were increased in apoE4 cells.
“Interestingly, the levels of all mitochondrial ribosomal proteins [109] detected by proteomics were increased.”
Quote in the paperNot a substantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
- Premisecitation
The single amino acid difference alters the intramolecular interactions in apoE4.
“which alters the intramolecular interactions in apoE4”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [15] Mahley, 1988, Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology, Science source
- Interpretationown data
ApoE4 impairs NAD+ synthetic capacity.
“Interestingly, the total NAD+ + NADH pool was smaller in the apoE4 cells, suggesting that apoE4 impairs NAD+ synthetic capacity [68].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [68] Verdin, 2015, NAD+ in aging, metabolism, and neurodegeneration, Science source
- Interpretationown data
The decrease in 33 of 64 detected subunits alters complex assembly.
“Our proteomic analysis showed that apoE4 decreased the levels of 33 of 64 detected subunits, undoubtedly altering complex assembly.”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Interpretationown data
Despite numerous cellular adaptations, apoE4-expressing neurons remained vulnerable to metabolic stress.
“despite numerous cellular adaptations, apoE4-expressing neurons remained vulnerable to metabolic stress”
Quote in the paperSubstantial claim - Interpretationreasoning
The altered stoichiometry of respiratory complex subunits could adversely affect various aspects of mitochondrial activity.
“Thus, the altered stoichiometry of respiratory complex subunits could adversely affect various aspects of mitochondrial activity.”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Interpretationreasoning
As a result, apoE4-expressing neuronal cells were more severely affected by stress.
“As a result, apoE4-expressing neuronal cells were more severely affected by stress.”
Quote in the paperSubstantial claim - Interpretationown data
ApoE4 disrupts the metabolism of glycolysis-derived pyruvate by pyruvate dehydrogenase (PDH).
“Our results suggest that apoE4 disrupts the metabolism of glycolysis-derived pyruvate by pyruvate dehydrogenase (PDH).”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Premisecitation
COX7a has a critical role in stabilizing complexes III and IV.
“For example, COX7a has a critical role in stabilizing complexes III and IV [39] and is significantly decreased in apoE4-expressing neurons.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [39] Letts, 2016, The architecture of respiratory supercomplexes, Nature source
- Interpretationown data
ApoE4 expression is associated with metabolic inflexibility under conditions of high-energy demand.
“Evidently, apoE4 expression is associated with metabolic inflexibility under conditions of high-energy demand.”
Quote in the paperSubstantial claim - Study design and conductown data
Total ATP content under the standard condition (Basal Glycolysis + Respiration) was the same in both cell lines.
“Total ATP content under the standard condition (“Basal Glycolysis + Respiration”) was the same in both cell lines”
Quote in the paperNot a substantial claim - Interpretationreasoning
The induction of specific enzymes likely accommodates altered metabolite fluxes in response to slowed respiration and NADH build-up.
“This induction of specific enzymes likely accommodates altered metabolite fluxes in response to slowed respiration and NADH build-up.”
Quote in the paperNot a substantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Interpretationown data
The glycolytic rate and ATP production were insufficient to maintain total cellular energy under conditions of high metabolic demand in apoE4 cells.
“Glycolysis was enhanced in apoE4 cells under basal conditions; however, the glycolytic rate and ATP production were insufficient to maintain total cellular energy under conditions of high metabolic demand.”
Quote in the paperSubstantial claim - Interpretationown data
ApoE4-induced bioenergetic deficits led to extensive metabolic rewiring.
“ApoE4-induced bioenergetic deficits led to extensive metabolic rewiring”
Quote in the paperSubstantial claim - Interpretationreasoning
Even if the interaction of apoE4 with mitochondria disrupts just a few critical assembly factors or subunits, it might cause the widespread depletion of functional complexes, impaired respiration, and the reduced ATP levels observed in the cells.
“Therefore, even if the interaction of apoE4 with mitochondria disrupts just a few critical assembly factors or subunits, it might cause the widespread depletion of functional complexes, impaired respiration, and the reduced ATP levels we observed in our cells.”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: Complex IV assembly requires the MITRAC assembly complex.
- Interpretationown data
Despite enhanced glycolysis under basal conditions, apoE4-expressing cells cannot call upon greater glycolytic reserves during periods of high energy demand to compensate for their lower respiration rate.
“despite enhanced glycolysis under basal conditions, apoE4-expressing cells cannot call upon greater glycolytic reserves during periods of high energy demand to compensate for their lower respiration rate”
Quote in the paperSubstantial claim - Interpretationreasoning
The profound effect on all detected subunit levels in complex V (ATP synthase) would disrupt mitochondrial ATP production.
“Likewise, the profound effect on all detected subunit levels in complex V (ATP synthase) would disrupt mitochondrial ATP production.”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Interpretationown data
ApoE4 cells regulate mitochondrial Ca2+ differently from apoE3 cells.
“Thus, apoE4 cells regulate mitochondrial Ca2+ differently from apoE3 cells.”
Quote in the paperSubstantial claim - Interpretationreasoning
Glycolysis in apoE4 cells was insufficient to compensate for the impaired mitochondrial ATP production during metabolic stress.
“Regardless, glycolysis in apoE4 cells was insufficient to compensate for the impaired mitochondrial ATP production during metabolic stress.”
Quote in the paperSubstantial claim - Interpretationreasoning
Ca2+ released from the ER of apoE4 cells flowed more quickly into mitochondria, bypassing the cytoplasm.
“The initial lower cytosolic Ca2+ influx coincided with the initial higher mitochondrial Ca2+ influx in apoE4 than in apoE3 cells, suggesting that Ca2+ released from the ER of apoE4 cells flowed more quickly into mitochondria, bypassing the cytoplasm.”
Quote in the paperSubstantial claim - Interpretationreasoning
Despite various adaptations, apoE4-expressing neuronal cells remained vulnerable to adverse metabolic events.
“Despite various adaptations, apoE4-expressing neuronal cells remained vulnerable to adverse metabolic events.”
Quote in the paperSubstantial claim - Interpretationreasoning
These changes in factors involved in mitochondrial morphology, biogenesis, and quality control may compensate for the large-scale apoE4-induced decreases in OXPHOS complexes.
“These changes in factors involved in mitochondrial morphology, biogenesis, and quality control may compensate for the large-scale apoE4-induced decreases in OXPHOS complexes.”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Interpretationreasoning
Mitochondrial-associated apoE4 disrupts the balance of core subunits of the respiratory complexes to prevent complete maturation of assembled complexes in the inner mitochondrial membrane.
“Judging from the broad effects of apoE4 on the respiratory complexes, we propose that mitochondrial-associated apoE4 disrupts the balance of core subunits of the respiratory complexes to prevent complete maturation of assembled complexes in the inner mitochondrial membrane.”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Interpretationreasoning
The increased levels of MAM proteins in apoE4-expressing cells might reflect increased tethering that is associated with the increased Ca2+ flux and increased ROS production observed.
“Thus, the increased levels of MAM proteins in apoE4-expressing cells might reflect increased tethering that is associated with the increased Ca2+ flux and increased ROS production we observed.”
Quote in the paperNot a substantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- May combine two claims. 33
- Classified as probably not a substantial claim. 38
- The quote only partly states this claim. 1
May combine two claims.
PremisecitationThe largest apoE4 fragment, apoE4(1-272), interacts directly with mitochondria to reduce mitochondrial membrane potential.
“The largest apoE4 fragment, apoE4(1–272), interacts directly with mitochondria to reduce mitochondrial membrane potential”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [10] Mahley, 2006, Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer’s disease, Proc Natl Acad Sci U S A source
In “ApoE4 Neuropathology Independent of Aβ” (page unavailable), the paper reports that apoE4(1–272) accumulates in mitochondria and that apoE fragments disrupt mitochondrial electropotential in cultured neurons. It does not establish that apoE4(1–272) directly binds mitochondria: the Mitochondrial Binding subsection says how the fragments associate with mitochondria is unknown and offers direct binding as one possibility. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [17] Chang, 2005, Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity, Proc Natl Acad Sci U S A source
The Results report that apoE4(1–272) was found in mitochondria and that cells expressing it had 25% lower MitoTracker fluorescence than cells expressing full-length apoE4. The paper explains that MitoTracker uptake depends on normal membrane potential, but describes the result as suggesting impaired mitochondrial function and integrity; it does not directly establish a reduction in membrane potential. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [20] Nakamura, 2009, Apolipoprotein E4 (1–272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells, Mol Neurodegener source
The Results section on mitochondrial membrane potential (page unavailable) reports no significant difference between Neuro2a cells expressing apoE4(1–272) and control cells, contrary to the claimed reduction. The paper does report that the fragment associates with mitochondrial proteins and reduces respiratory-complex III and IV activity, but those findings do not establish a reduction in membrane potential. (LLM, conf=0.94)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAccording to the MitoCarta 2.0 database, 654 proteins were specific to or associated with mitochondria.
“According to the MitoCarta 2.0 database [72], 654 proteins were specific to or associated with mitochondria.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [72] Calvo, 2016, MitoCarta2.0: An updated inventory of mammalian mitochondrial proteins, Nucleic Acids Res source
The Introduction and “Human and Mouse MitoCarta2.0” section state that the MitoCarta2.0 inventory contains 1,158 human genes and 1,158 mouse genes encoding mitochondrial proteins, not 654. No page number is available in our copy. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationCOX1 depletion results in defective assembly, and delivery of nuclear-encoded subunits reduces COX1 levels and also disrupts assembly.
“COX1 depletion results in defective assembly, and delivery of nuclear-encoded subunits reduces COX1 levels and also disrupts assembly [82–87].”
Quote in the paperNot a substantial claim4 of 6 sources checked- cites [82] Dennerlein, 2015, Human mitochondrial COX1 assembly into cytochromeoxidase at a glance, J Cell Sci source
- cites [83] Diaz, 2010, Cytochrome c oxidase deficiency: Patients and animal models, Biochim Biophys Acta source
Section 3.3.1 describes COX1 as the first assembly intermediate, supporting the link between COX1 depletion and defective assembly. Section 3.3 says assembly factors help transport nuclear-encoded subunits, but neither passage says that their delivery reduces COX1 levels; section 5.2 instead links impaired COX1 synthesis to a TACO1 mutation. Page numbers are unavailable in our copy. (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites [84] Mick David, 2012, MITRAC links mitochondrial protein translocation to respiratory-chain assembly and translational regulation, Cell source
The Results (page unavailable) report that MITRAC12 depletion reduces COX1 synthesis and the amount of newly synthesized COX1 in mature cytochrome c oxidase, supporting a link between COX1 loss and impaired assembly. They also show that TIM21 promotes assembly of an imported nuclear-encoded subunit. But the paper does not show that delivery of those subunits reduces COX1 levels; its Discussion describes reduced COX1 translation when the supply of imported subunits is limited, in yeast. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [85] Richter-Dennerlein, 2016, Mitochondrial protein synthesis adapts to influx of nuclear-encoded protein, Cell source
In Results, ‘Defects in COX1 Assembly Cause Accumulation of a Ribosome Nascent Chain Complex’ (page unavailable), the paper reports decreased COX1 and loss of functional complex IV when the nuclear-encoded subunit COX4 was depleted. The claim reverses that condition: it says delivery of nuclear-encoded subunits reduces COX1 and disrupts assembly, whereas the reported effect followed COX4 depletion. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured - cites [86] Richter-Dennerlein, 2015, Integrating mitochondrial translation into the cellular context, Nat Rev Mol Cell Biol source
- cites [87] Barrientos, 2009, Suppression mechanisms of COX asbly defects in yeast and human: Insights into the COX assembly process, Biochim Biophys Acta source
Section 2.4 reports that Cox1p synthesis is down-regulated in yeast when its assembly partners are absent, and that reduced Cox1p synthesis accompanies failed COX assembly. It does not say that delivery of nuclear-encoded subunits reduces COX1 levels; the reported relationship concerns the absence of assembly partners, not their delivery. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Classified as probably not a substantial claim.
PremisecitationApolipoprotein E4 is the major genetic risk factor for Alzheimer's disease.
“Apolipoprotein (apo) E4 is the major genetic risk factor for Alzheimer’s disease (AD)”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [1] Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families, Science source
- cites [2] Farrer, 1997, Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis, J Am Med Assoc source
- cites [3] Genin, 2011, APOE and Alzheimer disease: A major gene with semi-dominant inheritance, Mol Psychiatry source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationApoE4 occurs in approximately two-thirds of all Alzheimer's disease cases.
“occurs in approximately two-thirds of all cases [1–3]”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [1] Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families, Science source
- cites [2] Farrer, 1997, Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis, J Am Med Assoc source
- cites [3] Genin, 2011, APOE and Alzheimer disease: A major gene with semi-dominant inheritance, Mol Psychiatry source
The Introduction reports that APOE4 is enriched among Alzheimer’s disease patients, and the Results say genotype frequencies were estimated for cases. Neither passage gives a two-thirds figure for cases; the Discussion’s 0.09–0.30 figure concerns allele frequency in human populations, not the proportion of patients carrying APOE4. Page numbers are unavailable in our copy. (LLM, conf=0.78)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationApoE4 lowers the age of onset of Alzheimer's disease.
“lowers the age of onset [4–14]”
Quote in the paperNot a substantial claim9 of 10 sources checked- cites [4] Biundo, 2015, Interaction of apoE3 and apoE4 isoforms with an ITM2b/BRI2 mutation linked to the Alzheimer disease-like Danish dementia: Effects on learning and memory, Neurobiol Learn Mem source
- cites [5] Bu, 2009, Apolipoprotein E and its receptors in Alzheimer’s disease: Pathways, pathogenesis and therapy, Nat Rev Neurosci source
The Introduction identifies ApoE ε4 as a major risk factor for late-onset Alzheimer’s disease and says its effect on risk is greatest between ages 60 and 70. It does not state that carriers develop Alzheimer’s at a younger age than noncarriers, so the specific age-of-onset claim goes beyond what the copy reports. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [6] Holtzman, 2012, Apolipoprotein E and apolipoprotein E receptors: Normal biology and roles in Alzheimer disease, Cold Spring Harb Perspect Med source
- cites [7] Huang, 2012, Alzheimer mechanisms and therapeutic strategies, Cell source
- cites [8] Kim, 2009, The role of apolipoprotein E in Alzheimer’s disease, Neuron source
- cites [9] Liu, 2013, Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy, Nat Rev Neurol source
- cites [10] Mahley, 2006, Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer’s disease, Proc Natl Acad Sci U S A source
- cites [11] Mahley, 2009, Apolipoprotein E: Structure determines function, from atherosclerosis to Alzheimer’s disease to AIDS, J Lipid Res source
The Historical Background section identifies ApoE4 as a major genetic risk factor for Alzheimer’s disease, and the Neurodegenerative Disorders section describes its contribution to AD neuropathology. Neither passage states that ApoE4 lowers the age of AD onset; searches for age of onset and earlier onset found no such statement in our copy. Page numbers were not available. (LLM, conf=0.77)
Experimental — accuracy not yet measured - cites [12] Mahley, 2012, Apolipoprotein E sets the stage: Response to injury triggers neuropathology, Neuron source
- cites [13] Mahley, 2012, Small-molecule structure correctors target abnormal protein structure and function: The structure corrector rescue of apolipoprotein E–associated neuropathology, J Med Chem source
Classified as probably not a substantial claim.
PremisecitationCell-specific toxicity is the result of neuron-specific apoE4 proteolysis.
“Cell-specific toxicity is the result of neuron-specific apoE4 proteolysis [7, 12].”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [7] Huang, 2012, Alzheimer mechanisms and therapeutic strategies, Cell source
In the ApoE4 section, the paper says apoE4 proteolysis generates neurotoxic fragments in neurons but not astrocytes. It calls this “one potential mechanism” for the cell-source-dependent effects, so the claim overstates the certainty of the causal link. No page number is supplied in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [12] Mahley, 2012, Apolipoprotein E sets the stage: Response to injury triggers neuropathology, Neuron source
May combine two claims.
PremisecitationApoE fragments interact directly with mitochondria and disrupt their function.
“Although apoE fragments interact directly with mitochondria and disrupt their function [17, 20]”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [17] Chang, 2005, Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity, Proc Natl Acad Sci U S A source
- cites [20] Nakamura, 2009, Apolipoprotein E4 (1–272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells, Mol Neurodegener source
Classified as probably not a substantial claim. May combine two claims.
PremisecitationCompelling evidence links neurodegeneration to altered brain metabolism and mitochondrial dysfunction, both of which are early hallmarks of Alzheimer's disease.
“Compelling evidence links neurodegeneration to altered brain metabolism and mitochondrial dysfunction, both of which are early hallmarks of AD [21–28].”
Quote in the paperSubstantial claim4 of 8 sources checked- cites [21] Minoshima, 1997, Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease, Ann Neurol source
The Discussion reports severe metabolic reduction in the posterior cingulate cortex at a very early stage of Alzheimer’s disease and discusses a possible link to neural degeneration. It does not establish mitochondrial dysfunction as an early hallmark; its discussion of cytochrome oxidase concerns neuronal activity, not a finding of mitochondrial dysfunction. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [22] Kish, 1992, Brain cytochrome oxidase in Alzheimer’s disease, J Neurochem source
- cites [23] Maurer, 2000, A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients, Neurobiol Aging source
- cites [24] Liang, 2008, Alzheimer’s disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons, Proc Natl Acad Sci U S A source
- cites [25] Moreira, 2018, Sweet mitochondria: A shortcut to Alzheimer’s disease, J Alzheimers Dis source
The Introduction describes metabolic defects as characteristic of sporadic AD, and Author Views and Conclusions links defective brain glucose metabolism and mitochondrial anomalies to AD and neurodegeneration. That section also says mitochondrial defects seem to play an early role in AD development, but our copy does not establish that altered brain metabolism is likewise an early hallmark. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [26] Selfridge, 2013, Role of mitochondrial homeostasis and dynamics in Alzheimer’s disease, Neurobiol Dis source
- cites [27] Reddy, 2012, Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer’s disease: Implications to mitochondria-targeted antioxidant therapeutics, Biochim Biophys Acta source
Section 3.1 reports reduced brain glucose metabolism in AD, and sections 3 and 4.0 link mitochondrial dysfunction to AD pathology, including early deficits in a mouse model. The paper does not establish that altered brain metabolism itself is an early hallmark of AD; its glucose-metabolism passage does not address timing. No page numbers are available in our copy. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [28] Onyango, 2017, Mitochondria in the pathophysiology of Alzheimer’s and Parkinson’s diseases, Front Biosci source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAlterations in the integrity of mitochondria-ER-associated membranes have been linked to processes underlying dementia.
“Alterations in the integrity of MAM have been linked to processes underlying dementia [47–49].”
Quote in the paperNot a substantial claim3 of 3 sources checked- cites [47] Paillusson, 2016, There’s something wrong with my MAM; the ER–mitochondria axis and neurodegenerative diseases, Trends Neurosci source
- cites [48] Area-Gomez, 2018, A key role for MAM in mediating mitochondrial dysfunction in Alzheimer disease, Cell Death Dis source
- cites [49] Schon, 2011, Mitochondria: The next (neurode)generation, Neuron source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe aberrant proteolytic processing of apoE4 and consequent neurotoxicity can be blocked by treating apoE4-expressing cells with small-molecule structure correctors, which convert apoE4 to an apoE3-like conformation and prevent apoE4 fragment generation.
“The aberrant proteolytic processing of apoE4 and consequent neurotoxicity can be blocked by treating apoE4-expressing cells with small-molecule “structure correctors,” which convert apoE4 to an apoE3-like conformation and prevent apoE4 fragment generation [12, 13, 18, 19].”
Quote in the paperNot a substantial claim4 of 4 sources checked- cites [12] Mahley, 2012, Apolipoprotein E sets the stage: Response to injury triggers neuropathology, Neuron source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [13] Mahley, 2012, Small-molecule structure correctors target abnormal protein structure and function: The structure corrector rescue of apolipoprotein E–associated neuropathology, J Med Chem source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [18] Chen, 2011, Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease, J Biol Chem source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [19] Chen, 2012, Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons, J Biol Chem source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Classified as probably not a substantial claim.
PremisecitationApoE fragments engage in abnormal interactions in the cytosol that lead to neurodegeneration.
“where they engage in abnormal interactions that lead to neurodegeneration [17–19]”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [17] Chang, 2005, Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity, Proc Natl Acad Sci U S A source
- cites [18] Chen, 2011, Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease, J Biol Chem source
The Discussion (page not available in our copy) reports that an apoE4 fragment can bind mitochondrial respiratory-complex subunits and impair their activity. It does not place those interactions in the cytosol or establish that the fragment interactions lead to neurodegeneration; the paper links neurodegeneration more broadly to apoE4 domain interaction. (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites [19] Chen, 2012, Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons, J Biol Chem source
The Discussion (page unavailable) identifies neurotoxic apoE4 fragment formation among apoE4’s neuropathological features, and describes an abnormal interaction between domains of apoE4. It does not say that the fragments engage in abnormal interactions in the cytosol or that those interactions lead to neurodegeneration. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationMitochondria are involved in neuronal redox homeostasis, reactive oxygen species production, calcium buffering, and intracellular signaling.
“Mitochondria are also involved in neuronal redox homeostasis, reactive oxygen species (ROS) production, calcium buffering, and intracellular signaling [41–44].”
Quote in the paperNot a substantial claim3 of 4 sources checked- cites [41] Spinelli, 2018, The multifaceted contributions of mitochondria to cellular metabolism, Nat Cell Biol source
The sections “Mitochondria balance redox equivalents” and “ROS” describe mitochondrial roles in cellular redox balance, ROS production, and signaling (page numbers unavailable). They do not establish these roles specifically in neurons, and the searched passages do not address calcium buffering. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [42] Giorgi, 2018, The machineries, regulation and cellular functions of mitochondrial calcium, Nat Rev Mol Cell Biol source
The review describes mitochondrial calcium buffering in neurons (Mitochondria in Ca²⁺ Homeostasis, p. 11), links mitochondrial calcium handling to ROS generation (p. 12), and describes a role in cellular calcium signaling (Introduction, p. 4). It does not establish the claim about neuronal redox homeostasis specifically; its redox discussion is not framed as a neuronal finding. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [43] Angelova, 2018, Role of mitochondrial ROS in the brain: From physiology to neurodegeneration, FEBS Lett source
- cites [44] Shadel, 2015, Mitochondrial ROS signaling in organismal homeostasis, Cell source
The “Mitochondrial ROS Signaling” section describes mitochondrial ROS production and redox signaling, while the brain-focused sections discuss mitochondrial ROS control in neurons. “Mitochondria and Associated Homeostatic and Stress Signaling Pathways” also names ion homeostasis, but the passages do not establish the more specific claim of neuronal calcium buffering. Page numbers were not available in our copy. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationMany mitochondrial proteins must be assembled into large, multi-subunit structures, some of which form supercomplexes that are essential for mitochondrial energy metabolism.
“many must be assembled into large, multi-subunit structures, some of which form “supercomplexes” [39] that are essential for mitochondrial energy metabolism [40]”
Quote in the paperNot a substantial claim1 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationMitochondria communicate with the rest of the cell by metabolite shuttling, direct interactions with other organelles, and altered proteostasis.
“Mitochondria communicate with the rest of the cell by metabolite shuttling, direct interactions with other organelles, and altered proteostasis [36, 37].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [36] Chandel, 2014, Mitochondria as signaling organelles, BMC Biol source
- cites [37] Pellegrino, 2013, Signaling the mitochondrial unfolded protein response, Biochim Biophys Acta source
Section 5 describes a pathway in which mitochondrial protein-folding stress is transmitted to the nucleus, supporting communication through altered proteostasis. The passages do not describe metabolite shuttling or direct interactions with other organelles as communication routes. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationDirect interactions between mitochondria and the endoplasmic reticulum, particularly at mitochondria-ER-associated membranes, allow direct calcium exchange between the organelles and facilitate lipid synthesis, exchange, and metabolism.
“direct interactions between mitochondria and the endoplasmic reticulum (ER), particularly at mitochondria–ER-associated membranes (MAM), allow direct calcium exchange between the organelles and facilitate lipid synthesis, exchange, and metabolism [45, 46]”
Quote in the paperNot a substantial claim2 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationExtra-mitochondrial Ca2+ enters the mitochondria via outer membrane voltage-dependent anion channels (VDACs) and the mitochondrial Ca2+ uniporter on the inner membrane.
“Extra-mitochondrial Ca2+ enters the mitochondria via outer membrane voltage-dependent anion channels (VDACs) and the mitochondrial Ca2+ uniporter on the inner membrane [71].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [71] Brisac, 2010, Calcium flux between the endoplasmic reticulum and mitochondrion contributes to poliovirus-induced apoptosis, J Virol source
The Results and Discussion state that mitochondrial Ca2+ uptake occurs through VDAC and the Ca2+ uniporter, and report inhibition of uptake when either channel is blocked in poliovirus-infected IMR5 cells. Our copy does not explicitly locate VDAC in the outer membrane or the uniporter in the inner membrane, so it does not support that part of the sentence. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPreviously, the authors reported deficits in single subunits of each of the OXPHOS complexes in apoE4-expressing neuronal cells.
“Previously, we reported deficits in single subunits of each of the OXPHOS complexes in the apoE4-expressing neuronal cells [18].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [18] Chen, 2011, Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease, J Biol Chem source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationDisruption of the communication networks between mitochondria and the rest of the cell is thought to contribute to aging and neurodegeneration.
“Disruption of the communication networks between mitochondria and the rest of the cell is thought to contribute to aging and neurodegeneration [50, 51].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [50] source
Not checked in the free run.
- cites [51] Carvalho, 2009, Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia, J Bioenerg Biomembr source
The “Mitochondria and the brain” section (page unavailable) says that excess reactive oxygen species activate anomalous signaling and discusses mitochondrial damage during aging. The “Is mitochondrial dysfunction a necessary step in neurodegeneration?” section (page unavailable) links mitochondrial dysfunction to Alzheimer’s disease. The copy does not specifically say that disrupted communication between mitochondria and the rest of the cell contributes to aging. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Classified as probably not a substantial claim.
PremisecitationNormal respiration requires the coordinated production of subunits for proper assembly into functional complexes.
“Normal respiration requires the coordinated production of subunits for proper assembly into functional complexes [81].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [81] Fernández-Vizarra, 2009, Assembly of the oxidative phosphorylation system in humans: What we have learned by studying its defects, Biochim Biophys Acta source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThapsigargin-induced Ca2+ transfer from the ER to mitochondria depends on IP3R in the ER and VDACs on the outer mitochondrial membrane.
“Furthermore, thapsigargin-induced Ca2+ transfer from the ER to mitochondria depends on IP3R in the ER and VDACs on the outer mitochondrial membrane [93, 94].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [93] Deniaud, 2008, Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis, Oncogene source
- cites [94] Bravo, 2012, Endoplasmic reticulum: ER stress regulates mitochondrial bioenergetics, Int J Biochem Cell Biol source
Section 2.2 identifies IP3R and VDAC as the main ER–mitochondria Ca2+ transfer channels on the ER and mitochondrial sides, respectively. Section 3 describes mitochondrial uptake of Ca2+ released through ER-localized IP3R. The copy does not establish that thapsigargin-induced transfer specifically depends on both channels. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationRespiratory complexes consist of 13 subunits encoded by mitochondrial DNA and 78 encoded by nuclear DNA.
“Respiratory complexes consist of 13 subunits encoded by mitochondrial DNA and 78 encoded by nuclear DNA [80].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [80] Signes, 2018, Assembly of mammalian oxidative phosphorylation complexes I–V and supercomplexes, Essays Biochem source
The Introduction and the sections on complexes I, III, IV and V describe subunits encoded by mitochondrial and nuclear DNA; their accounts identify seven, one, three and two mitochondrial-encoded subunits, respectively, supporting the total of 13. Our copy does not state a total of 78 nuclear-encoded subunits, so that number is not verified. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationMAM participate in lipid synthesis, membrane stability, mitochondrial dynamics, and ROS signaling.
“Besides controlling Ca2+ flux, MAM participate in lipid synthesis, membrane stability, mitochondrial dynamics, and ROS signaling [99–101].”
Quote in the paperNot a substantial claim3 of 3 sources checked- cites [99] Rowland, 2012, Endoplasmic reticulum–mitochondria contacts: Function of the junction, Nat Rev Mol Cell Biol source
The “Lipid exchange during biosynthesis” section says the MAM fraction is enriched in lipid-synthesis enzymes, and “Regulating mitochondrial dynamics and inheritance” links ER–mitochondria contacts to mitochondrial dynamics. The passages do not establish membrane stability or ROS signaling as functions of MAM. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [100] Phillips, 2016, Structure and function of ER membrane contact sites with other organelles, Nat Rev Mol Cell Biol source
The ER–mitochondria section on lipid biosynthesis and exchange describes phospholipid synthesis and transfer at the contact interface; the Organelle biogenesis > ER–mitochondria section says contact sites help position mitochondrial fission. The passages located do not establish a role in membrane stability or ROS signaling. The discussion of stability in “MCS-bound organelles in motion” concerns the stability of contact sites, not membranes; page numbers are unavailable in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [101] Rieusset, 2018, The role of endoplasmic reticulum-mitochondria contact sites in the control of glucose homeostasis: An update, Cell Death Dis source
The Inter-organelle signalling section describes lipid synthesis and exchange at MAMs and ROS-mediated signalling. The Metabolic interplay section links MAMs to mitochondrial dynamics. Neither section establishes a role in membrane stability; the paper’s references to MAM integrity concern ER–mitochondria contacts, not membrane stability. Page numbers were unavailable in our copy. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThese factors, including nuclear respiratory factor 1, nuclear factor erythroid-2-like 2, GA binding protein (nuclear respiratory factor 2), and Sp4, directly and indirectly control the expression of respiratory chain subunits encoded by nuclear and mitochondrial DNA.
“These factors, including nuclear respiratory factor 1, nuclear factor erythroid-2-like 2, GA binding protein (nuclear respiratory factor 2), and Sp4 [110–114] directly and indirectly control the expression of respiratory chain subunits encoded by nuclear and mitochondrial DNA [110, 115, 116].”
Quote in the paperNot a substantial claim5 of 7 sources checked- cites [110] Scarpulla, 2005, Nuclear control of respiratory gene expression in mammalian cells, J Cell Biochem source
- cites [111] Ohtsuji, 2008, Nrf1 and Nrf2 play distinct roles in activation of antioxidant response element-dependent genes, J Biol Chem source
The Abstract (page not available) identifies Nrf2 as a transcription factor that regulates antioxidant and xenobiotic-metabolizing genes, supporting its inclusion among the named factors. The paper does not establish that these factors control respiratory-chain subunits encoded by nuclear or mitochondrial DNA; searches for respiratory-chain and mitochondrial terms returned no such passage. Its Nrf1 is a Cap’n’Collar factor, not the nuclear respiratory factor 1 named in the claim. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [112] Yang, 2014, GABP transcription factor (nuclear respiratory factor 2) is required for mitochondrial biogenesis, Mol Cell Biol source
- cites [113] Holmström, 2016, The multifaceted role of Nrf2 in mitochondrial function, Curr Opin Toxicol source
The “Nrf2 and mitochondrial homeostasis” section reports that Nrf2 stimulates mitochondrial biogenesis through activation of nuclear respiratory factor 1. The stem-cell section also describes Nrf2 activating Pitx2, which then activates components of the electron transport chain. These passages support an indirect role for Nrf2, but do not establish the stated direct and indirect control of respiratory-chain subunit genes encoded by both nuclear and mitochondrial DNA, or address GA binding protein and Sp4. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [114] Dinkova-Kostova, 2015, The emerging role of Nrf2 in mitochondrial function, Free Radic Biol Med source
The “Nrf2 and mitochondrial biogenesis” section (page unavailable) says nuclear respiratory factors 1 and 2 control genes encoding respiratory-complex subunits, and that Nrf2 can promote mitochondrial biogenesis through nuclear respiratory factor 1. The copy also reports Nrf2-associated changes in respiratory-chain proteins. It does not establish the claimed role for Sp4 or show that these factors control expression of subunits encoded by mitochondrial DNA. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [115] Dhar, 2008, Nuclear respiratory factor 1 regulates all ten nuclear-encoded subunits of cytochrome c oxidase in neurons, J Biol Chem source
- cites [116] Johar, 2013, Neuron-specific specificity protein 4 bigenomically regulates the transcription of all mitochondria- and nucleus-encoded cytochrome c oxidase subunit genes in neurons, J Neurochem source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIncreased tethering may be associated with neurodegeneration, including the risk of AD.
“Increased tethering may be associated with neurodegeneration, including the risk of AD [103].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [103] Schon, 2013, Mitochondria-associated ER membranes in Alzheimer disease, Mol Cell Neurosci source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationFission/fusion processes help modulate mitochondrial function in both normal and pathological conditions.
“Fission/fusion processes help modulate mitochondrial function in both normal and pathological conditions [105].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [105] Youle, 2012, Mitochondrial fission, fusion, and stress, Science source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationOther important MAM tethering proteins are B-cell receptor-associated protein 31, mitochondrial fission 1 protein, and mitofusin.
“Other important MAM tethering proteins are B-cell receptor–associated protein 31, mitochondrial fission 1 protein [96], and mitofusin [97].”
Quote in the paperNot a substantial claim1 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIP3R and VDACs are MAM components that tether the ER to mitochondria through the molecular chaperone GRP75.
“IP3R and VDACs are MAM components that tether the ER to mitochondria through the molecular chaperone GRP75 [95].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [95] Szabadkai, 2006, Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels, J Cell Biol source
The ER–mitochondria interface section reports IP3R, VDAC1 and grp75 in the MAM fraction and a shared complex, with grp75 proposed to scaffold the two channels. The Discussion calls grp75 the key assembling molecule in their loose interaction. This supports channel coupling at the interface, but does not establish that the complex physically tethers the ER and mitochondria. (LLM, conf=0.83)
Experimental — accuracy not yet measured
May combine two claims.
Findingown dataWhen forced to use mitochondria to generate ATP, both cell lines grew slower than under basal conditions, but the slowing was significantly greater in apoE4-expressing cells.
“When forced to use mitochondria to generate ATP, both cell lines grew slower than under basal conditions, a response common in cells restricted to grow only on mitochondrial energy production [66]; however, the slowing was significantly greater in the apoE4-expressing cells.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataApoE4 expression altered the levels of 44% of MitoCarta mitochondrial proteins, with similar numbers significantly increased or decreased.
“ApoE4 expression altered the levels of 44% of these proteins; similar numbers were significantly increased or decreased.”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
May combine two claims.
Findingown dataThere were significant alterations in NADH shuttle components, NAD(P)-dependent metabolic enzymes, numerous cytosolic and mitochondrial antioxidant enzymes, and the NAD synthetic enzyme NAMPT in apoE4 cells.
“For example, there were significant alterations in NADH shuttle components (components of both malate-aspartate and glycerol phosphate shuttles), NAD(P)-dependent metabolic enzymes [NAD(P)-dehydrogenase (which converts NADH into NADPH)], numerous cytosolic and mitochondrial antioxidant enzymes, and the NAD synthetic enzyme NAMPT (Fig. 6).”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
May combine two claims.
Findingown dataOver one-third of detected proteins differed in expression between apoE4 and apoE3 cells, with similar numbers significantly increased or decreased.
“Over one-third differed in their expression in apoE4 versus apoE3 cells; similar numbers of proteins were significantly increased or decreased (p < 0.05).”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
The quote only partly states this claim.
Findingown dataMitochondrial Ca2+ levels 8 min after extracellular Ca2+ addition were twofold higher in apoE4-expressing cells than in apoE3-expressing cells.
“In contrast, in response to extracellular Ca2+, both the basal mitochondrial Ca2+ level (Fig. 4E) and the rate of Ca2+ influx into mitochondria in response to extracellular Ca2+ were much greater in cells expressing apoE4 (Fig. 4F, H), culminating in twofold higher levels of mitochondrial Ca2+ (Fig. 4G).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPathways enriched with proteins significantly increased by apoE4 were strongly related to RNA-related processes, whereas pathways enriched with proteins significantly decreased by apoE4 were heavily involved in OXPHOS, including ATP binding, ATP metabolic processes, ATP synthesis, and metabolism.
“Broadly speaking, in addition to mitochondrion and mitochondrial inner membrane proteins, pathways enriched with proteins significantly increased by apoE4 were strongly related to RNA-related processes, whereas pathways and processes enriched with proteins significantly decreased by apoE4 were heavily involved in OXPHOS, including ATP binding, ATP metabolic processes, ATP synthesis, and metabolism”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
May combine two claims.
Findingown dataThe levels of 42% of the 953 mitochondria-associated proteins were significantly changed by apoE4 expression, with equal numbers increased and decreased.
“Using the MitoMiner 4.0 database [73] and the Gene Ontology “Mitochondrion” category [74, 75], we identified 953 proteins associated with mitochondria; the levels of 42% of those proteins were significantly changed by apoE4 expression, again with equal numbers increased and decreased (Fig. 5A).”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
May combine two claims.
Findingown dataWhen mitochondria were forced to produce ATP from pyruvate oxidation in the absence of glucose (stimulated respiration only), total ATP levels decreased markedly in both cell lines, but apoE4-expressing cells had a small, significantly greater deficit in energy levels.
“However, when the mitochondria were forced to produce ATP from pyruvate oxidation in the absence of glucose (stimulated respiration only), total ATP levels decreased markedly in both cell lines, but the apoE4-expressing cells had a small, but significantly greater deficit in energy levels (Fig. 2A).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe levels of all 33 subunits altered by apoE4 were significantly decreased, as was the level of cytochrome c.
“Remarkably, the levels of all 33 subunits altered by apoE4 were significantly decreased (p < 0.05), as was the level of cytochrome c.”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataLists of proteins significantly increased (501 proteins) or decreased (606 proteins) at a p < 0.01 threshold were queried together to identify transcription factors most likely to drive coordinated changes in protein expression in N2a-apoE4 cells.
“lists of proteins significantly increased (501 proteins) or decreased (606 proteins) at a p < 0.01 threshold were queried together to identify the transcription factors most likely to drive the coordinated changes in protein expression in N2a-apoE4 cells”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataProteomic analysis revealed a remarkable reduction in the levels of 50% of detected subunits of mitochondrial respiratory complexes I-V; none were increased.
“Proteomic analysis revealed a remarkable reduction in the levels of 50% of detected subunits of mitochondrial respiratory complexes I–V; none were increased.”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
May combine two claims.
Findingown dataAlthough the cytosolic Ca2+ level did not differ between apoE3- and apoE4-expressing cells at 8 min, the rate of cytosolic Ca2+ influx was twofold higher in apoE4 cells.
“Although the cytosolic Ca2+ level did not differ between apoE3- and apoE4-expressing cells at 8 min (Fig. 4C), the rate of cytosolic Ca2+ influx was twofold higher in apoE4 cells (Fig. 4D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOf six detected MAM tethering proteins, the levels of five were increased in apoE4-expressing cells and the level of one (GRP75) was decreased.
“Of six detected tethering proteins, the levels of five were increased in apoE4-expressing cells and the level of one (GRP75) was decreased (Fig. 8B).”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataA total of 65 OXPHOS subunits plus cytochrome c were detected.
“A total of 65 subunits plus cytochrome c were detected (Fig. 7A).”
Quote in the paperNot a substantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
May combine two claims.
Findingown dataAssociated with impaired mitochondrial activity were a decreased NAD+/NADH ratio and increased levels of mitochondrial Ca2+ and cellular ROS.
“Associated with the impaired mitochondrial activity were a decreased NAD+/NADH ratio and increased levels of mitochondrial Ca2+ and cellular ROS.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataLive-cell imaging showed an increase in mitochondrial Ca2+ and faster mitochondrial Ca2+ uptake during thapsigargin-induced Ca2+ release from the ER.
“Live-cell imaging showed an increase in mitochondrial Ca2+ and faster mitochondrial Ca2+ uptake during thapsigargin-induced Ca2+ release from the ER.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe levels of all 12 subunits detected in complex V (ATP synthase) were decreased, some by greater than 50%.
“Most strikingly, the levels of all 12 subunits detected in complex V (ATP synthase) were decreased, some by greater than 50% (Fig. 7B).”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
May combine two claims.
Findingown dataNumerous proteins linked to mitochondrial morphology and to the synthesis, import, maturation, and degradation of mitochondrial proteins were coordinately changed in apoE4 cells, with most proteins in these pathways showing increased expression.
“Numerous proteins linked to mitochondrial morphology and to the synthesis, import, maturation, and degradation of mitochondrial proteins were also coordinately changed in apoE4 cells, with most proteins in these pathways showing increased expression (Fig. 9).”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
May combine two claims.
Findingown dataThe levels of the translocases of both the outer and inner mitochondrial membrane (the TOM and TIM complexes) and three of four TOM-associated factors were increased in apoE4 cells.
“Also increased were levels of the translocases of both the outer and inner mitochondrial membrane (the TOM and TIM complexes), which control the delivery of cytosolic proteins to the mitochondria, and three of four TOM-associated factors [106].”
Quote in the paperNot a substantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
- Rests on an assumption: The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe vast majority of mitochondrial proteins require import, proteolytic maturation, and delivery to the correct submitochondrial compartment.
“the vast majority of mitochondrial proteins require import, proteolytic maturation, and delivery to the correct submitochondrial compartment [38]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [38] Rampelt, 2016, Coordination of two genomes by mitochondrial translational plasticity, Cell source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationApoE4 differs from apoE3 by a single amino acid.
“ApoE4 differs from apoE3 by a single amino acid [15]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] Mahley, 1988, Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology, Science source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataProtein content did not differ in equivalent numbers of N2a-apoE3 and N2a-apoE4 cells.
“Protein content did not differ in equivalent numbers of N2a-apoE3 and N2a-apoE4 cells.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataApoE4 expression impairs mitochondrial energy production, leading to metabolic inflexibility and inability to respond to metabolic demand.
“Thus, apoE4 expression impairs mitochondrial energy production, leading to metabolic inflexibility and inability to respond to metabolic demand.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataMitochondria in apoE4 cells have a higher resting level of Ca2+ and accumulate Ca2+ faster and to higher levels.
“Thus, mitochondria in apoE4 cells have a higher resting level of Ca2+ and accumulate Ca2+ faster and to higher levels.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductnone givenAll peptide and protein identifications were filtered to a 1% false-discovery rate.
“all peptide and protein identifications were filtered to a 1% false-discovery rate”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenTitration of metabolic modulators was performed to ensure no differential sensitivities existed between N2a-apoE3 and N2a-apoE4 cells and that fully inhibited or stimulated rates were always obtained for each Seahorse run.
“Titration of metabolic modulators was performed to ensure no differential sensitivities existed between N2a-apoE3 and N2a-apoE4 cells and that fully inhibited or stimulated rates were always obtained for each Seahorse run.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataMitochondrial Ca2+ overload in apoE4-expressing neurons promotes mitochondrial impairment and neurodegeneration.
“Our findings on Ca2+ fluxes imply that mitochondrial Ca2+ overload in apoE4-expressing neurons promotes mitochondrial impairment and neurodegeneration.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataApoE4-expressing cells appear to lack both the capacity to meet high levels of energy demand and the metabolic flexibility to respond to stress.
“apoE4-expressing cells appear to lack both the capacity to meet high levels of energy demand and the metabolic flexibility to respond to stress”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThree independent sets of cultures were harvested separately but processed in parallel for LC-MS/MS analysis.
“Three independent sets of cultures were harvested separately but processed in parallel for LC-MS/MS analysis.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
InterpretationreasoningThe initiating event may involve disruptions in the production/delivery of OXPHOS subunits and the assembly of the OXPHOS complexes.
“The initiating event may involve disruptions in the production/delivery of OXPHOS subunits and the assembly of the OXPHOS complexes.”
Quote in the paperSubstantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
InterpretationreasoningThese changes could reflect an attempt to restore normal mitochondrial function.
“These changes could reflect an attempt to restore normal mitochondrial function.”
Quote in the paperNot a substantial claim- Rests on an assumption: Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIncreased expression of mitofusin enhances the interaction between VDAC1 and IP3R.
“Increased expression of mitofusin enhances the interaction between VDAC1 and IP3R [98].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [98] Tubbs, 2014, Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance, Diabetes source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIncreased expression of MAM proteins enhances tethering between the organelles and modulates connectivity/conductivity.
“Increased expression of MAM proteins enhances tethering between the organelles and modulates connectivity/conductivity [102].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [102] Naon, 2014, At the right distance: ER-mitochondria juxtaposition in cell life and death, Biochim Biophys Acta source
The paper relies on this without support.
The extent to which apoE4 disrupts mitochondrial function and cellular metabolism in neurons remains poorly defined.
“the extent to which apoE4 disrupts mitochondrial function and cellular metabolism in neurons remains poorly defined”
The paper relies on this without support.
ApoE4’s effect on mitochondrial respiration and metabolism is not understood in detail.
“apoE4’s effect on mitochondrial respiration and metabolism is not understood in detail”
The paper relies on this without support.
When injured or stressed, neurons increase apoE synthesis.
“When injured or stressed, neurons increase apoE synthesis.”
The paper relies on this without support.
Changes in protein levels detected by proteomics produce corresponding functional changes in the affected pathways.
“ApoE4 altered a wide range of proteins involved in OXPHOS, redox homeostasis, and glucose and amino acid metabolism (Fig. 6).”
The paper relies on this without support.
The N2a neuronal cell model recapitulates the cell-autonomous effects of apoE4 in human neurons relevant to neurodegeneration.
“Label-free, quantitative proteomic profiling of whole-cell lysates from N2a-apoE3 and N2a-apoE4 cells by LC-MS/MS identified approximately 4500 distinct proteins (Fig. 5A).”
The paper relies on this without support.
Complex IV assembly requires the MITRAC assembly complex.
“For example, complex IV assembly requires the MITRAC assembly complex, a central component of which, MITRAC12, was reduced by 47% in apoE4-expressing cells (p < 1×10–9).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Impaired calcium flux has been observed in vitro in an APOE4-expressing neuronal cell line compared with an APOE3-expressing line and could be partially responsible for the hyperexcitability seen in APOE4 neurons in culture.
“Impaired calcium flux has been observed in vitro in an APOE4-expressing neuronal cell line compared with an APOE3-expressing line and could be partially responsible for the hyperexcitability seen in APOE4 neurons in culture173.”
From Multifaceted roles of APOE in Alzheimer disease (2024) · cites this paper as [173]
The Results section (page unavailable) reports altered calcium flux in cultured N2a-apoE4 cells compared with N2a-apoE3 cells, including faster mitochondrial calcium uptake. The cited paper does not establish or propose that this alteration contributes to hyperexcitability in APOE4 neurons; its Discussion instead links mitochondrial calcium overload to mitochondrial impairment and neurodegeneration. (LLM, conf=0.86)
Experimental — accuracy not yet measuredAPOE-dependent alterations in mitochondrial fusion/fission protein levels have been shown in other studies; however, those were contradictory.
“In contrast, APOE-dependent alterations in mitochondrial fusion/fission protein levels have been shown in other studies; however, those were contradictory.”
From APOE4 Increases Energy Metabolism in APOE-Isogenic iPSC-Derived Neurons (2024) · cites this paper as [33]
The Results (Fig. 9; page unavailable) and Discussion report that apoE4 altered levels of mitochondrial fusion/fission proteins in this study. They do not say that other studies found such alterations or that those studies contradicted one another. (LLM, conf=0.84)
Experimental — accuracy not yet measuredApoE4 (272-299 aa fragment) increases ROS levels in N2a cell line.
“ApoE4 (272–299 aa fragment) was demonstrated to increase ROS levels in N2a cell line [28,73]”
From Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies (2023) · cites this paper as [73]
The Results (Fig. 3B; page unavailable) report approximately twofold higher ROS levels in N2a cells expressing apoE4 than in cells expressing apoE3. But Materials and Methods (Cell lines; page unavailable) specifies full-length apoE4, not a 272–299 amino-acid fragment, so the fragment-specific claim is not supported. (LLM, conf=0.90)
Experimental — accuracy not yet measuredAPOE4 N2A cells expressed higher levels of fission and fusion proteins than APOE3 N2A cells.
“MFN1, MFN2, OPA1, and FIS1 levels were decreased in the brains and neurons of AD patients and APOE4 carriers [37,38], whereas APOE4 N2A cells expressed higher levels of fission and fusion proteins than APOE3 N2A cells [33].”
From APOE4 Increases Energy Metabolism in APOE-Isogenic iPSC-Derived Neurons (2024) · cites this paper as [33]
Neuronal APOE4 expression reduced the levels of mitochondrial respiratory complex subunits compared to APOE3 neurons.
“Neuronal APOE4 expression reduced the levels of mitochondrial respiratory complex subunits compared to APOE3 neurons [32,33].”
From APOE4 Increases Energy Metabolism in APOE-Isogenic iPSC-Derived Neurons (2024) · cites this paper as [33]
Some studies indicated mitochondrial downregulation and decreased ATP production, contrary to the authors' findings of mitochondrial upregulation and enhanced ATP production in APOE4 cells.
“However, contrary to our findings of mitochondrial upregulation and enhanced ATP production in APOE4 cells, some studies indicated mitochondrial downregulation and decreased ATP production.”
From APOE4 Increases Energy Metabolism in APOE-Isogenic iPSC-Derived Neurons (2024) · cites this paper as [33]
In ApoE4-expressing N2a cells, decrease in respiration rates and ATP production, showing poorer ability to respond to high energy demands relative to ApoE3-expressing cells.
“in other studies performed in ApoE4-expressing N2a cells, the authors demonstrated a decrease in respiration rates and ATP production, showing a poorer ability to respond to high energy demands relative to ApoE3-expressing cells [73].”
From Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies (2023) · cites this paper as [73]
Overexpression of some MAM proteins in N2a cells expressing ApoE4, including VDAC1 and IP3R, in agreement with higher and faster Ca2+ flux from ER to mitochondria, comparing to ApoE3 expression.
“Other studies have also shown an overexpression of some MAM proteins in N2a cells expressing ApoE4, including voltage-dependent anion-selective channel 1 (VDAC1) and inositol 1,4,5-trisphosphate receptor (IP3R), in agreement with a higher and faster Ca2+ flux from the ER to mitochondria, comparing to ApoE3 expression [73].”
From Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies (2023) · cites this paper as [73]
Association between ApoE4 expression and mitochondrial Ca2+ overload was observed in in vitro models, such as Neuro-2 A cells, stem-cell-derived forebrain excitatory neurons and rat hippocampal neurons.
“an association between ApoE4 expression and mitochondrial Ca2+ overload was observed in in vitro models, such as Neuro-2 A cells [28,73], stem-cell-derived forebrain excitatory neurons [50] and rat hippocampal neurons [30].”
From Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies (2023) · cites this paper as [73]
ApoE4 largest fragment (1-272 aa) directly interacts with mitochondria, leading to decrease in Δψm and mitochondrial fragmentation.
“ApoE4 largest fragment (1–272 aa) was shown to directly interact with mitochondria, which leads to a decrease in Δψm and mitochondrial fragmentation [26,29,73].”
From Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies (2023) · cites this paper as [73]
ApoE4-expressing neuronal cells have widespread changes in mitochondrial protein production and translocation.
“as well as widespread changes in mitochondrial protein production and translocation”
From Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease (2019) · cites this paper as [191]
ApoE4-expressing neuronal cells have 50% less reserve capacity to generate ATP than apoE3-expressing neuronal cells.
“A recent study reports that apoE4-expressing neuronal cells have 50% less reserve capacity to generate ATP than apoE3-expressing neuronal cells”
From Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease (2019) · cites this paper as [191]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Conflicting counts of detected respiratory-complex subunits
MinorThe Results say 65 respiratory-complex subunits were detected, excluding cytochrome c, but the Discussion says 64 were detected.
“A total of 65 subunits plus cytochrome c were detected (Fig. 7A).”
“Our proteomic analysis showed that apoE4 decreased the levels of 33 of 64 detected subunits, undoubtedly altering complex assembly.”
Conflicting reductions in OXPHOS-dependent ATP production
MinorThe Results report a 33% lower OXPHOS ATP production rate in apoE4 cells, whereas the Discussion describes OXPHOS-dependent ATP production as 40-50% lower.
“ATP production rates by OXPHOS in apoE4 cells were 33% lower”
“We found that mitochondrial respiration and OXPHOS-dependent ATP production are impaired in apoE4-expressing cells, being 40–50% lower than in apoE3-expressing cells.”
Cites
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206 · see citing works
KEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077 · see citing works
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890 · see citing works
KEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232 · see citing works
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855 · see citing works
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · see citing works
KEGG: new perspectives on genomes, pathways, diseases and drugs
Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y., & Morishima, K. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1092 · Cited by 8,865 · see citing works
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207 · see citing works
KEGG as a reference resource for gene and protein annotation
Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M., & Tanabe, M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1070 · Cited by 7,387 · see citing works
Cox, J., Hein, M. Y., Luber, C. A., Paron, I., Nagaraj, N., & Mann, M. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.031591 · Cited by 5,180 · see citing works
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028 · see citing works
Self-citationMitochondrial Fission, Fusion, and Stress
Youle, R. J., & van der Bliek, A. M. (2012) · Science · doi:10.1126/science.1219855 · Cited by 3,674 · see citing works
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459 · see citing works
Targeting the KEAP1-NRF2 system to prevent kidney disease progression
Nezu, M., Suzuki, N., & Yamamoto, M. (2017) · American Journal of Nephrology · doi:10.1159/000475890 · Cited by 3,447 · see citing works
From genomics to chemical genomics: new developments in KEGG
Kanehisa, M. I. (2005) · Nucleic Acids Research · doi:10.1093/nar/gkj102 · Cited by 3,126 · see citing works
Calcium, ATP, and ROS: a mitochondrial love-hate triangle
Brookes, P. S., Yoon, Y., Robotham, J. L., Anders, M. W., & Sheu, S.-S. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00139.2004 · Cited by 2,575 · see citing works
Mitofusin 2 tethers endoplasmic reticulum to mitochondria
de Brito, O. M., & Scorrano, L. (2008) · Nature · doi:10.1038/nature07534 · Cited by 2,442 · see citing works
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019 · see citing works
The multifaceted contributions of mitochondria to cellular metabolism
Spinelli, J. B., & Haigis, M. C. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0124-1 · Cited by 1,935 · see citing works
Expansion of the Gene Ontology knowledgebase and resources
The Gene Ontology Consortium (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1108 · Cited by 1,850 · see citing works
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease
Minoshima, S., Giordani, B., Berent, S., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1997) · Annals of Neurology · doi:10.1002/ana.410420114 · Cited by 1,802 · see citing works
Alzheimer Mechanisms and Therapeutic Strategies
Huang, Y., & Mucke, L. (2012) · Cell · doi:10.1016/j.cell.2012.02.040 · Cited by 1,758 · see citing works
The role of apolipoprotein E in Alzheimer's disease
Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661 · see citing works
Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels
Szabadkai, G., Bianchi, K., Várnai, P., De Stefani, D., Wieckowski, M. R., Cavagna, D., Nagy, A. I., Balla, T., & Rizzuto, R. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200608073 · Cited by 1,413 · see citing works
Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366 · see citing works
Mitochondrial ROS Signaling in Organismal Homeostasis
Shadel, G. S., & Horvath, T. L. (2015) · Cell · doi:10.1016/j.cell.2015.10.001 · Cited by 1,353 · see citing works
NAD <sup>+</sup> in aging, metabolism, and neurodegeneration
Verdin, E. (2015) · Science · doi:10.1126/science.aac4854 · Cited by 1,319 · see citing works
Zhang, H., Ryu, D., Wu, Y., Gariani, K., Wang, X., Luan, P., D’Amico, D., Ropelle, E. R., Lutolf, M. P., Aebersold, R., et al. (2016) · Science · doi:10.1126/science.aaf2693 · Cited by 1,255 · see citing works
MitoCarta2.0: an updated inventory of mammalian mitochondrial proteins
Calvo, S. E., Clauser, K. R., & Mootha, V. K. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1003 · Cited by 1,251 · see citing works
Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy
Bu, G. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2620 · Cited by 1,168 · see citing works
Choi, M., Chang, C.-Y., Clough, T., Broudy, D., Killeen, T., MacLean, B., & Olga Vitek, A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu305 · Cited by 1,041 · see citing works
Endoplasmic reticulum-mitochondria contacts: Function of the junction
Rowland, A. A., & Voeltz, G. K. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3440 · Cited by 1,018 · see citing works
The emerging role of Nrf2 in mitochondrial function
Dinkova-Kostova, A. T., & Abramov, A. Y. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.04.036 · Cited by 983 · see citing works
Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia
Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., Saunders, A. M., & Hardy, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2635903100 · Cited by 977 · see citing works
The machineries, regulation and cellular functions of mitochondrial calcium
Giorgi, C., Marchi, S., & Pinton, P. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0052-8 · Cited by 941 · see citing works
Structure and function of ER membrane contact sites with other organelles
Phillips, M. J., & Voeltz, G. K. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2015.8 · Cited by 933 · see citing works
Mahley, R. W., Weisgraber, K. H., & Huang, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600549103 · Cited by 912 · see citing works
Self-citationCerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer’s disease
Small, G. W., Ercoli, L. M., Silverman, D. H. S., Huang, S.-C., Komo, S., Bookheimer, S. Y., Lavretsky, H., Miller, K., Siddarth, P., Rasgon, N. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090106797 · Cited by 790 · see citing works
Role of mitochondrial <scp>ROS</scp> in the brain: from physiology to neurodegeneration
Angelova, P. R., & Abramov, A. Y. (2018) · FEBS Letters · doi:10.1002/1873-3468.12964 · Cited by 789 · see citing works
MAM: more than just a housekeeper
Hayashi, T., Rizzuto, R., Hajnoczky, G., & Su, T.-P. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.12.002 · Cited by 787 · see citing works
Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease
Holtzman, D. M., Herz, J., & Bu, G. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006312 · Cited by 782 · see citing works
APOE and Alzheimer disease: a major gene with semi-dominant inheritance
Genin, E., Hannequin, D., Wallon, D., Sleegers, K., Hiltunen, M., Combarros, O., Bullido, M. J., Engelborghs, S., De Deyn, P., Berr, C., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.52 · Cited by 714 · see citing works
Deniaud, A., Sharaf el dein, O., Maillier, E., Poncet, D., Kroemer, G., Lemaire, C., & Brenner, C. (2008) · Oncogene · doi:10.1038/sj.onc.1210638 · Cited by 586 · see citing works
Liang, W. S., Reiman, E. M., Valla, J., Dunckley, T., Beach, T. G., Grover, A., Niedzielko, T. L., Schneider, L. E., Mastroeni, D., Caselli, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709259105 · Cited by 585 · see citing works
Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS
Mahley, R. W., Weisgraber, K. H., & Huang, Y. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800069-jlr200 · Cited by 580 · see citing works
Self-citationMitochondria as signaling organelles
Chandel, N. S. (2014) · BMC Biology · doi:10.1186/1741-7007-12-34 · Cited by 576 · see citing works
Mitochondria: The Next (Neurode)Generation
Schon, E. A., & Przedborski, S. (2011) · Neuron · doi:10.1016/j.neuron.2011.06.003 · Cited by 568 · see citing works
Mookerjee, S. A., Gerencser, A. A., Nicholls, D. G., & Brand, M. D. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.774471 · Cited by 550 · see citing works
Brain cytochrome oxidase in Alzheimer's disease
Kish, S. J., Bergeron, C., Rajput, A., Dozic, S., Mastrogiacomo, F., Chang, L., Wilson, J. M., DiStefano, L. M., & Nobrega, J. N. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09439.x · Cited by 537 · see citing works
Fis1 and Bap31 bridge the mitochondria–ER interface to establish a platform for apoptosis induction
Iwasawa, R., Mahul‐Mellier, A., Datler, C., Pazarentzos, E., & Grimm, S. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.346 · Cited by 520 · see citing works
Titov, D. V., Cracan, V., Goodman, R. P., Peng, J., Grabarek, Z., & Mootha, V. K. (2016) · Science · doi:10.1126/science.aad4017 · Cited by 518 · see citing works
The architecture of respiratory supercomplexes
Letts, J. A., Fiedorczuk, K., & Sazanov, L. A. (2016) · Nature · doi:10.1038/nature19774 · Cited by 490 · see citing works
Nuclear control of respiratory gene expression in mammalian cells
Scarpulla, R. C. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20743 · Cited by 489 · see citing works
A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients
Maurer, I. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00112-3 · Cited by 475 · see citing works
There's Something Wrong with my MAM; the ER–Mitochondria Axis and Neurodegenerative Diseases
Paillusson, S., Stoica, R., Gomez-Suaga, P., Lau, D. H. W., Mueller, S., Miller, T., & Miller, C. C. J. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.01.008 · Cited by 439 · see citing works
Apolipoprotein e sets the stage: response to injury triggers neuropathology
Mahley, R. W., & Huang, Y. (2012) · Neuron · doi:10.1016/j.neuron.2012.11.020 · Cited by 412 · see citing works
Self-citationTubbs, E., Theurey, P., Vial, G., Bendridi, N., Bravard, A., Chauvin, M.-A., Ji-Cao, J., Zoulim, F., Bartosch, B., Ovize, M., et al. (2014) · Diabetes · doi:10.2337/db13-1751 · Cited by 411 · cited 4× · see citing works
“Increased expression of mitofusin enhances the interaction between VDAC1 and IP3R [98].”
BackgroundInfluentialZambelli, F., Pesole, G., & Pavesi, G. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp464 · Cited by 402 · see citing works
Reddy, P. H., Tripathi, R., Troung, Q., Tirumala, K., Reddy, T. P., Anekonda, V., Shirendeb, U. P., Calkins, M. J., Reddy, A. P., Mao, P., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.011 · Cited by 394 · see citing works
Huang, Y., Liu, X. Q., Wyss-Coray, T., Brecht, W. J., Sanan, D. A., & Mahley, R. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151254698 · Cited by 392 · see citing works
Self-citationIncreasing NADH oxidation reduces overflow metabolism in Saccharomyces cerevisiae
Vemuri, G. N., Eiteman, M. A., McEwen, J. E., Lisbeth Olsson, A., & Nielsen, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607469104 · Cited by 373 · see citing works
The multifaceted role of Nrf2 in mitochondrial function
Holmström, K. M., Kostov, R. V., & Dinkova-Kostova, A. T. (2016) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2016.10.002 · Cited by 368 · see citing works
Signaling the mitochondrial unfolded protein response
Pellegrino, M. W., Nargund, A. M., & Haynes, C. M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.02.019 · Cited by 359 · see citing works
New functions of mitochondria associated membranes in cellular signaling
van Vliet, A. R., Verfaillie, T., & Agostinis, P. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.03.009 · Cited by 353 · see citing works
The contributions of respiration and glycolysis to extracellular acid production
Mookerjee, S. A., Goncalves, R. L. S., Gerencser, A. A., Nicholls, D. G., & Brand, M. D. (2014) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2014.10.005 · Cited by 347 · see citing works
The Protein Import Machinery of Mitochondria
Wiedemann, N., Frazier, A. E., & Pfanner, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400003200 · Cited by 336 · see citing works
Chang, S., Ma, T. R., Miranda, R. D., Balestra, M. E., Mahley, R. W., & Huang, Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508254102 · Cited by 319 · see citing works
Self-citationNrf1 and Nrf2 Play Distinct Roles in Activation of Antioxidant Response Element-dependent Genes
Ohtsuji, M., Katsuoka, F., Kobayashi, A., Aburatani, H., Hayes, J. D., & Yamamoto, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804597200 · Cited by 317 · see citing works
Friedman, J. R., Mourier, A., Yamada, J., McCaffery, J. M., & Nunnari, J. (2015) · eLife · doi:10.7554/elife.07739 · Cited by 291 · see citing works
Assembly of mammalian oxidative phosphorylation complexes I–V and supercomplexes
Signes, A., & Fernandez-Vizarra, E. (2018) · Essays in Biochemistry · doi:10.1042/ebc20170098 · Cited by 267 · see citing works
Mitochondria-associated ER membranes in Alzheimer disease
Schon, E. A., & Area-Gomez, E. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.07.011 · Cited by 261 · see citing works
Protein Degradation within Mitochondria: Versatile Activities of AAA Proteases and Other Peptidases
Koppen, M., & Langer, T. (2007) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230701380452 · Cited by 252 · see citing works
Mick, D. U., Dennerlein, S., Wiese, H., Reinhold, R., Pacheu-Grau, D., Lorenzi, I., Sasarman, F., Weraarpachai, W., Shoubridge, E. A., Warscheid, B., et al. (2012) · Cell · doi:10.1016/j.cell.2012.11.053 · Cited by 250 · see citing works
Rieusset, J. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0416-1 · Cited by 248 · see citing works
A key role for MAM in mediating mitochondrial dysfunction in Alzheimer disease
Area-Gomez, E., de Groof, A., Bonilla, E., Montesinos, J., Tanji, K., Boldogh, I., Pon, L., & Schon, E. A. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0215-0 · Cited by 235 · see citing works
Mitochondrial protein synthesis adapts to influx of nuclear-encoded protein
Richter-Dennerlein, R., Oeljeklaus, S., Lorenzi, I., Ronsör, C., Bareth, B., Schendzielorz, A. B., Wang, C., Warscheid, B., Rehling, P., & Dennerlein, S. (2016) · Cell · doi:10.1016/j.cell.2016.09.003 · Cited by 232 · see citing works
Fernández-Vizarra, E., Tiranti, V., & Zeviani, M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.05.028 · Cited by 214 · see citing works
Chen, H.-K., Ji, Z.-S., Dodson, S. E., Miranda, R. D., Rosenblum, C. I., Reynolds, I. J., Freedman, S. B., Weisgraber, K. H., Huang, Y., & Mahley, R. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.151084 · Cited by 209 · see citing works
Self-citationFluge, Ø., Mella, O., Bruland, O., Risa, K., Dyrstad, S. E., Alme, K., Rekeland, I. G., Sapkota, D., Røsland, G. V., Fosså, A., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.89376 · Cited by 209 · see citing works
Suppressors of superoxide production from mitochondrial complex III
Orr, A. L., Vargas, L., Turk, C. N., Baaten, J., Matzen, J., Dardov, V. J., Attle, S. J., Li, J., Quackenbush, D., Goncalves, R. L. S., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1910 · Cited by 207 · see citing works
Self-citationElk-1 a Transcription Factor with Multiple Facets in the Brain
Besnard, A., Galan-Rodriguez, B., Vanhoutte, P., & Caboche, J. (2011) · Frontiers in Neuroscience · doi:10.3389/fnins.2011.00035 · Cited by 195 · see citing works
Mitochondrial proteostasis in the context of cellular and organismal health and aging
Moehle, E. A., Shen, K., & Dillin, A. G. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.tm117.000893 · Cited by 193 · see citing works
Endoplasmic reticulum: ER stress regulates mitochondrial bioenergetics
Bravo, R., Gutierrez, T., Paredes, F., Gatica, D., Rodriguez, A. E., Pedrozo, Z., Chiong, M., Parra, V., Quest, A. F. G., Rothermel, B. A., et al. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.10.012 · Cited by 191 · see citing works
Gohil, V. M., Sheth, S., Nilsson, R., Wojtovich, A. P., Lee, J. H., Perocchi, F., Chen, W., Clish, C., Ayata, C., Brookes, P., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1606 · Cited by 191 · see citing works
Dhar, S. S., Ongwijitwat, S., & Wong-Riley, M. T. T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707587200 · Cited by 188 · see citing works
Mitochondria-associated ER membranes and Alzheimer disease
Área-Gómez, E., & Schon, E. A. (2016) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.04.006 · Cited by 186 · see citing works
Wu, L., Zhang, X., & Zhao, L. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.2262-17.2018 · Cited by 185 · see citing works
At the right distance: ER-mitochondria juxtaposition in cell life and death
Naon, D., & Scorrano, L. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.05.011 · Cited by 178 · see citing works
Role of mitochondrial homeostasis and dynamics in Alzheimer's disease
Selfridge, J. E., E, L., Lu, J., & Swerdlow, R. H. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.057 · Cited by 175 · see citing works
Determining Maximum Glycolytic Capacity Using Extracellular Flux Measurements
Mookerjee, S. A., Nicholls, D. G., & Brand, M. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152016 · Cited by 167 · see citing works
ApoE4 upregulates the activity of mitochondria‐associated ER membranes
Tambini, M. D., Pera, M., Kanter, E., Yang, H., Guardia‐Laguarta, C., Holtzman, D., Sulzer, D., Area‐Gomez, E., & Schon, E. A. (2016) · The EMBO Reports · doi:10.15252/embr.201540614 · Cited by 166 · see citing works
Wanka, C., Steinbach, J., & Rieger, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.384578 · Cited by 165 · see citing works
Chen, H.-K., Liu, Z., Meyer-Franke, A., Brodbeck, J., Miranda, R. D., McGuire, J. G., Pleiss, M. A., Ji, Z.-S., Balestra, M. E., Walker, D. W., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.276162 · Cited by 163 · see citing works
Self-citationMitoMiner v3.1, an update on the mitochondrial proteomics database
Smith, A. C., & Robinson, A. J. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1001 · Cited by 162 · see citing works
PASTAA: identifying transcription factors associated with sets of co-regulated genes
Roider, H. G., Manke, T., O'Keeffe, S., Vingron, M., & Haas, S. A. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btn627 · Cited by 154 · see citing works
Ikeda, K., Shiba, S., Horie-Inoue, K., Shimokata, K., & Inoue, S. (2013) · Nature Communications · doi:10.1038/ncomms3147 · Cited by 152 · see citing works
Harris, F. M., Brecht, W. J., Xu, Q., Mahley, R. W., & Huang, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408127200 · Cited by 151 · see citing works
Self-citationValla, J., Yaari, R., Wolf, A. B., Kusne, Y., Beach, T. G., Roher, A. E., Corneveaux, J. J., Huentelman, M. J., Caselli, R. J., & Reiman, E. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100129 · Cited by 150 · see citing works
Taherzadeh-Fard, E., Saft, C., Akkad, D. A., Wieczorek, S., Haghikia, A., Chan, A., Epplen, J. T., & Arning, L. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-32 · Cited by 134 · see citing works
Mahley, R. W., & Huang, Y. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3008618 · Cited by 132 · see citing works
Self-citationCytochrome c oxidase deficiency: Patients and animal models
Diaz, F. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.07.013 · Cited by 127 · see citing works
Farrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124 · see citing works
Nakamura, T., Watanabe, A., Fujino, T., Hosono, T., & Michikawa, M. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-35 · Cited by 124 · see citing works
Mitochondrial ribosomal proteins: Candidate genes for mitochondrial disease
Sylvester, J. E., Fischel‐Ghodsian, N., Mougey, E. B., & O’Brien, T. W. (2004) · Genetics in Medicine · doi:10.1097/01.gim.0000117333.21213.17 · Cited by 122 · see citing works
Brodbeck, J., McGuire, J., Liu, Z., Meyer-Franke, A., Balestra, M. E., Jeong, D.-E., Pleiss, M., McComas, C., Hess, F., Witter, D., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.217380 · Cited by 113 · see citing works
Self-citationGABP Transcription Factor (Nuclear Respiratory Factor 2) Is Required for Mitochondrial Biogenesis
Yang, Z.-F., Drumea, K., Mott, S., Wang, J., & Rosmarin, A. G. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00492-12 · Cited by 112 · see citing works
Mitochondria in the pathophysiology of Alzheimer s and Parkinson s diseases
Onyango, I. G. (2017) · Frontiers in Bioscience · doi:10.2741/4521 · Cited by 107 · see citing works
Barrientos, A., Gouget, K., Horn, D., Soto, I. C., & Fontanesi, F. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.05.003 · Cited by 99 · see citing works
Alzheimer's disease: The forgetting gene
Spinney, L. (2014) · Nature · doi:10.1038/510026a · Cited by 98 · see citing works
ER–Mitochondrial Calcium Flow Underlies Vulnerability of Mechanosensory Hair Cells to Damage
Esterberg, R., Hailey, D. W., Rubel, E. W., & Raible, D. W. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0281-14.2014 · Cited by 96 · see citing works
Brodbeck, J., Balestra, M. E., Saunders, A. M., Roses, A. D., Mahley, R. W., & Huang, Y. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709906104 · Cited by 86 · see citing works
Self-citationIntegrating mitochondrial translation into the cellular context
Richter-Dennerlein, R., Dennerlein, S., & Rehling, P. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4051 · Cited by 81 · see citing works
Human mitochondrial COX1 assembly into cytochrome <i>c</i> oxidase at a glance
Dennerlein, S., & Rehling, P. (2015) · Journal of Cell Science · doi:10.1242/jcs.161729 · Cited by 79 · see citing works
Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia
Carvalho, C., Correia, S. C., Santos, R. X., Cardoso, S., Moreira, P. I., Clark, T. A., Zhu, X., Smith, M. A., & Perry, G. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9247-1 · Cited by 72 · see citing works
Brisac, C., Téoulé, F., Autret, A., Pelletier, I., Colbère-Garapin, F., Brenner, C., Lemaire, C., & Blondel, B. (2010) · Journal of Virology · doi:10.1128/jvi.00994-10 · Cited by 65 · see citing works
Mendelsohn, B. A., Bennett, N. K., Darch, M. A., Yu, K., Nguyen, M. K., Pucciarelli, D., Nelson, M. R., Horlbeck, M. A., Gilbert, L. A., Hyun, W. C., et al. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2004624 · Cited by 55 · see citing works
Hypermethylation of TRIM59 and KLF14 Influences Cell Death Signaling in Familial Alzheimer’s Disease
Wężyk, M., Spólnicka, M., Pośpiech, E., Pepłońska, B., Zbieć-Piekarska, R., Ilkowski, J., Styczyńska, M., Barczak, A. K., Zboch, M., Filipek-Gliszczyńska, A., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6918797 · Cited by 35 · see citing works
Sp3 and Sp4 Transcription Factor Levels Are Increased in Brains of Patients with Alzheimer’s Disease
Boutillier, S., Lannes, B., Buée, L., Delacourte, A., Rouaux, C., Mohr, M., Bellocq, J., Sellal, F., Larmet, Y., Boutillier, A., et al. (2007) · Neurodegenerative Diseases · doi:10.1159/000107701 · Cited by 33 · see citing works
Protein–protein interaction analysis using an affinity peptide tag and hydrophilic polystyrene plate
Kumada, Y., ZHAO, C., ISHIMURA, R., Imanaka, H., IMAMURA, K., & Nakanishi, K. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2006.09.018 · Cited by 30 · see citing works
Johar, K., Priya, A., Dhar, S., Liu, Q., & Wong‐Riley, M. T. T. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12433 · Cited by 25 · see citing works
Urfer-Buchwalder, A., & Urfer, R. (2017) · Scientific Reports · doi:10.1038/srep40668 · Cited by 20 · see citing works
Sweet Mitochondria: A Shortcut to Alzheimer’s Disease
Moreira, P. I. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170931 · Cited by 20 · see citing works
Biundo, F., Ishiwari, K., Del Prete, D., & D’Adamio, L. (2015) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2015.10.009 · Cited by 13 · see citing works
Coordination of Two Genomes by Mitochondrial Translational Plasticity
Rampelt, H., & Pfanner, N. (2016) · Cell · doi:10.1016/j.cell.2016.09.042 · Cited by 9 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1074/jbc.TM1117.000893 · DOI
Cited by
Sorted by citations
Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
Cunnane, S. C., Trushina, E., Morland, C., Prigione, A., Casadesus, G., Andrews, Z. B., Beal, M. F., Bergersen, L. H., Brinton, R. D., de la Monte, S., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0072-x · Cited by 1,003 · see citing works
Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal-network activity
Victor, M. B., Leary, N., Luna, X., Meharena, H. S., Scannail, A. N., Bozzelli, P. L., Samaan, G., Murdock, M. H., von Maydell, D., Effenberger, A. H., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.07.005 · Cited by 316 · see citing works
Mitochondria and Calcium in Alzheimer’s Disease: From Cell Signaling to Neuronal Cell Death
Calvo-Rodriguez, M., & Bacskai, B. J. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2020.10.004 · Cited by 254 · see citing works
Cell type‐specific roles of APOE4 in Alzheimer disease
Blumenfeld, J., Yip, O., Kim, M. J., & Huang, Y. (2024) · Nature Reviews Neuroscience · doi:10.1038/s41583-023-00776-9 · Cited by 202 · see citing works
Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease
Najm, R., Jones, E. A., & Huang, Y. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0324-6 · Cited by 183 · see citing works
Multifaceted roles of APOE in Alzheimer disease
Jackson, R. J., Hyman, B. T., & Serrano-Pozo, A. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00988-2 · Cited by 193 · see citing works
Zalocusky, K. A., Najm, R., Taubes, A. L., Hao, Y., Yoon, S. Y., Koutsodendris, N., Nelson, M. R., Rao, A., Bennett, D. A., Bant, J., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00851-3 · Cited by 189 · see citing works
Mitochondrial Dysfunction in Alzheimers Disease: Opportunities forDrug Development
Bhatia, S., Rawal, R., Sharma, P., Singh, T., Singh, M., & Singh, V. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210517114016 · Cited by 197 · see citing works
Pires, M., & Rego, A. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010778 · Cited by 157 · see citing works
Ca2+ handling at the mitochondria-ER contact sites in neurodegeneration
Lim, D., Dematteis, G., Tapella, L., Genazzani, A. A., Calí, T., Brini, M., & Verkhratsky, A. (2021) · Cell Calcium · doi:10.1016/j.ceca.2021.102453 · Cited by 105 · see citing works
Roles of ApoE4 on the Pathogenesis in Alzheimer’s Disease and the Potential Therapeutic Approaches
Sun, Y.-Y., Wang, Z., & Huang, H. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01365-1 · Cited by 95 · see citing works
Farmer, B. C., Williams, H. C., Devanney, N. A., Piron, M. A., Nation, G. K., Carter, D. J., Walsh, A. E., Khanal, R., Young, L. E. A., Kluemper, J. C., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00483-y · Cited by 87 · see citing works
Oxygen metabolism abnormality and Alzheimer's disease: An update
Liu, G., Yang, C., Wang, X., Chen, X., Wang, Y., & Le, W. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102955 · Cited by 85 · see citing works
Parodi‐Rullán, R. M., Javadov, S. A., & Fossati, S. (2021) · Cells · doi:10.3390/cells10112903 · Cited by 75 · see citing works
The ATP Synthase Deficiency in Human Diseases
Galber, C., Carissimi, S., Baracca, A., & Giorgio, V. (2021) · Life · doi:10.3390/life11040325 · Cited by 70 · see citing works
Mitochondria in Alzheimer’s Disease Pathogenesis
Reiss, A. B., Gulkarov, S., Jacob, B., Srivastava, A., Pinkhasov, A., Gomolin, I. H., Stecker, M. M., Wısnıewskı, T., & Leon, J. D. (2024) · Life · doi:10.3390/life14020196 · Cited by 62 · see citing works
Molecular Dysfunctions of Mitochondria-Associated Membranes (MAMs) in Alzheimer’s Disease
Eysert, F., Kinoshita, P., Mary, A., Vaillant-Beuchot, L., Checler, F., & Chami, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249521 · Cited by 53 · see citing works
ATP synthase and Alzheimer’s disease: putting a spin on the mitochondrial hypothesis
Ebanks, B., Ingram, T. L., & Chakrabarti, L. (2020) · Aging · doi:10.18632/aging.103867 · Cited by 58 · see citing works
Mechanistic insights and emerging therapeutic stratagems for Alzheimer’s disease
Rajendran, K., & Krishnan, U. M. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102309 · Cited by 58 · see citing works
Liang, T., Hang, W., Chen, J., Wu, Y., Wen, B., Xu, K., Ding, B., & Chen, J. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00563-y · Cited by 54 · see citing works
Apolipoprotein E regulates mitochondrial function through the PGC-1α-sirtuin 3 pathway
Yin, J., Nielsen, M., Carcione, T., Li, S., & Shi, J. (2019) · Aging · doi:10.18632/aging.102516 · Cited by 53 · see citing works
Jung, H., Kim, S. Y., Cecen, F. S. C., Cho, Y., & Kwon, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.599792 · Cited by 52 · see citing works
Henderson, S. T., Morimoto, B. H., Cummings, J. L., Farlow, M. R., & Walker, J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191302 · Cited by 49 · see citing works
Friend or foe: Lactate in neurodegenerative diseases
Wang, M., Zhou, Y., Li, W., Zhu, L., & Liu, D. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102452 · Cited by 48 · see citing works
Chen, Y., Jin, H., Chen, J., Li, J., Găman, M., & Zou, Z. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02600-y · Cited by 52 · see citing works
Mitochondrial dysfunction in cellular senescence: a bridge to neurodegenerative disease
Hruby, A. J., & Higuchi‐Sanabria, R. (2025) · npj Aging · doi:10.1038/s41514-025-00291-4 · Cited by 44 · see citing works
Mahley, R. W. (2023) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2023.102684 · Cited by 43 · see citing works
Self-citationSirtuin 3 (SIRT3) Pathways in Age-Related Cardiovascular and Neurodegenerative Diseases
Silaghi, C. N., Farcas, M. F., & Craciun, A. M. (2021) · Biomedicines · doi:10.3390/biomedicines9111574 · Cited by 37 · see citing works
Barnett, D., Zimmer, T. S., Booraem, C., Palaguachi, F., Meadows, S. M., Xiao, H., Wong, M. Y., Luo, W., Gan, L., Chouchani, E. T., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01390-y · Cited by 39 · see citing works
Self-citationAPOE expression and secretion are modulated by mitochondrial dysfunction
Wynne, M. E., Ogunbona, O., Lane, A. R., Gokhale, A., Zlatic, S. A., Xu, C., Wen, Z., Duong, D. M., Rayaprolu, S., Ivanova, A., et al. (2023) · eLife · doi:10.7554/elife.85779 · Cited by 35 · see citing works
Calderón‐Garcidueñas, L., Hernández-Luna, J., Aiello-Mora, M., Brito-Aguilar, R., Evelson, P., Villarreal-Ríos, R., Torres‐Jardón, R., Ayala, A., & Mukherjee, P. S. (2023) · Biomolecules · doi:10.3390/biom13060927 · Cited by 28 · see citing works
Functional diversity of apolipoprotein E: from subcellular localization to mitochondrial function
Rueter, J., Rimbach, G. H., & Huebbe, P. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04516-7 · Cited by 31 · see citing works
Impact of Genetic Risk Factors for Alzheimer’s Disease on Brain Glucose Metabolism
Cho, S., Lee, H., & Seo, J. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02297-x · Cited by 25 · see citing works
Zhang, Y., Sheng, Z., Su, C., Xia, Y., Chen, X., Huang, X., Li, H., Ma, C., & Wang, L. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/4026688 · Cited by 25 · see citing works
Zhang, X., Wu, L., Swerdlow, R. H., & Zhao, L. (2023) · Cells · doi:10.3390/cells12030410 · Cited by 22 · see citing works
Mitochondrial fission and fusion in neurodegenerative diseases:Ca2+ signalling
Liu, X., Li, T., Tu, X., Xu, M., & Wang, J. (2025) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2025.103992 · Cited by 21 · see citing works
Lysosomal proteomics reveals mechanisms of neuronal APOE4-associated lysosomal dysfunction
Krogsaeter, E., McKetney, J., Valiente‐Banuet, L., Marquez, A., Willis, A., Cakir, Z., Stevenson, E. J., Jang, G. Μ., Rao, A. T., Li, E., et al. (2025) · Autophagy · doi:10.1080/15548627.2025.2576613 · Cited by 22 · see citing works
Self-citationA Review of ApoE4 Interference Targeting Mitophagy Molecular Pathways for Alzheimer's Disease
Chen, H., Chen, F., Jiang, Y., Zhang, L., Hu, G., Sun, F., Zhang, M., Ji, Y., Chen, Y., Che, G., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.881239 · Cited by 19 · see citing works
Laparra, I. C., Juárez‐Escoto, E., Vicario‐Abejón, C., Moratalla, R., & García‐Sanz, P. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1087072 · Cited by 17 · see citing works
Slayo, M., Rummel, C. D., Singhaarachchi, P. H., Feldotto, M., & Spencer, S. J. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00824-1 · Cited by 16 · see citing works
Ragupathy, H., Vukku, M., & Barodia, S. K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914421 · Cited by 15 · see citing works
APOE4 Increases Energy Metabolism in APOE-Isogenic iPSC-Derived Neurons
Budny, V., Knöpfli, Y., Meier, D., Zürcher, K., Bodenmann, C., Peter, S. L., Müller, T., Tardy, M., Cortijo, C., & Tackenberg, C. (2024) · Cells · doi:10.3390/cells13141207 · Cited by 15 · see citing works
Phu, T. A., Vu, N. K., Ng, M., Gao, A. S., Stoolman, J. S., Chandel, N. S., & Raffaı̈, R. L. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113206 · Cited by 16 · see citing works
Gudenschwager, C., Chavez, I., Cárdenas, C., & González-Billault, C. E. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5586052 · Cited by 12 · see citing works
Kulkarni, P. G., Mohire, V. M., Waghmare, P. P., & Banerjee, T. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101874 · Cited by 16 · see citing works
Imaging mitochondrial calcium dynamics in the central nervous system
Serrat, R., Oliveira-Pinto, A., Marsicano, G., & Pouvreau, S. (2022) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2022.109560 · Cited by 13 · see citing works
Matsui, A., Kobayashi, J., Kanno, S., Hashiguchi, K., Miyaji, M., Yoshikawa, Y., Yasui, A., & Zhang-Akiyama, Q.-M. (2019) · Journal of Radiation Research · doi:10.1093/jrr/rrz080 · Cited by 13 · see citing works
Tau phosphorylation and OPA1 proteolysis are unrelated events: Implications for Alzheimer's Disease
Alavi, M. V. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119116 · Cited by 12 · see citing works
Cakir, Z., Lord, S. J., Zhou, Y. M., Jang, G. Μ., Polacco, B. J., Eckhardt, M., Jimenez‐Morales, D., Newton, B. W., Orr, A. L., Johnson, J. R., et al. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100541 · Cited by 10 · see citing works
Self-citationGenetic ablation of neuronal mitochondrial calcium uptake impedes Alzheimer’s disease progression
Jadiya, P., Berezhnaya, E. V., Kolmetzky, D. W., Tomar, D., Cohen, H. M., Shukla, S., Thomas, M., Khaledi, S., Garbincius, J. F., Kennedy, L., et al. (2026) · The EMBO Journal · doi:10.1038/s44318-026-00809-w · Cited by 10 · see citing works
E2F4-Based Gene Therapy Mitigates the Phenotype of the Alzheimer's Disease Mouse Model 5xFAD
López‐Sánchez, N., Garrido‐García, A., Ramón‐Landreau, M., Cano‐Daganzo, V., & Frade, J. M. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01151-1 · Cited by 9 · see citing works
Signs of Alzheimer’s Disease: Tied to Aging
Chen, J., Zhu, Z., & Xu, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26114974 · Cited by 8 · see citing works
Beresford‐Webb, J., McAllister, C. J., Sleigh, A., Walpert, M., Holland, A. J., & Zaman, S. H. (2025) · Brain Sciences · doi:10.3390/brainsci15020130 · Cited by 10 · see citing works
A Mutant Variant of E2F4 Triggers Multifactorial Therapeutic Effects in 5xFAD Mice
López‐Sánchez, N., Ramón‐Landreau, M., Trujillo, C., Garrido‐García, A., & Frade, J. M. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02764-z · Cited by 8 · see citing works
Asiamah, E. A., Feng, B., Guo, R., Yaxing, X., Du, X., Liu, X., Zhang, J., Cui, H., & Ma, J. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230658 · Cited by 8 · see citing works
Rueter, J., Rimbach, G. H., Bilke, S., Tholey, A., & Huebbe, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910597 · Cited by 7 · see citing works
Zuniga, N. R., Earls, N. E., Denos, A. E. A., Elison, J. M., Jones, B. S., Smith, E. G., Moran, N. G., Broce, K. L., Romero, G. M., Hyer, C. D., et al. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012407 · Cited by 6 · see citing works
Apoliprotein E-mediated ferroptosis controls cellular proliferation in chronic lymphocytic leukemia
Nardi, F., Prete, R. D., Drago, R., Rita, A. D., Vallone, F. E., Ciofini, S., Malchiodi, M., Pezzella, L., Tinti, L., Cicaloni, V., et al. (2024) · Leukemia · doi:10.1038/s41375-024-02442-0 · Cited by 6 · see citing works
Ramón‐Landreau, M., Sánchez‐Puelles, C., López‐Sánchez, N., Lozano-Ureña, A., Llabrés-Mas, A. M., & Frade, J. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012093 · Cited by 6 · see citing works
Rueter, J., Rimbach, G. H., Treitz, C., Schloesser, A., Lüersen, K., Tholey, A., & Huebbe, P. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04706-x · Cited by 5 · see citing works
Xu, J., Duan, J., Cai, Z., Arai, C., Di, C., Venters, C. C., Xu, J., Jones, M., So, B. R., & Dreyfuss, G. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.09.617477 · Cited by 6 · see citing works
Mitochondrial dysfunction in Alzheimer's disease and related sex differences
Misrani, A., Ngwa, C., & Liu, F. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1761702 · Cited by 5 · see citing works
Cheng, Y., Li, Y., Liang, X., Wang, P., Fa, W., Liu, C., Wang, Y., Liu, K., Wang, N., & Du, Y. (2022) · Clinical Interventions in Aging · doi:10.2147/cia.s345784 · Cited by 4 · see citing works
The role of domain alterations in F1Fo-ATPase dysfunction associated to neurodegenerative diseases
Zhou, M., Lin, Y., Zhang, Z., Tang, Y., Zhang, W., Liu, H., Peng, G., Qiu, J., Guo, W., Chen, X., et al. (2023) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2022.28 · Cited by 4 · see citing works
Johnson, C. N., Lysaker, C. R., Gast, E. C., McCoin, C. S., Kemna, R. E., Fuller, K. N. Z., Kugler, B. A., Franczak, E., Csikós, V., Allen, J., et al. (2025) · Function · doi:10.1093/function/zqaf017 · Cited by 3 · see citing works
Johnson, C. N., McCoin, C. S., Kueck, P. J., Hawley, A. G., John, C. S., Thyfault, J. P., Swerdlow, R. H., Geiger, P. C., & Morris, J. K. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221192 · Cited by 4 · see citing works
Tice, C. M., Zhao, H., & Langford, D. (2023) · Journal of NeuroVirology · doi:10.1007/s13365-023-01126-2 · Cited by 3 · see citing works
Müller Glial Kir4.1 Channel Dysfunction in APOE4 ‐ KI Model of Alzheimer's Disease
Abhyankar, S. D., Xiao, Y., Mahajan, N. S., Luo, Q., Cummins, T., Oblak, A. L., Lamb, B. T., Corson, T. W., & Bhatwadekar, A. D. (2026) · Glia · doi:10.1002/glia.70119 · Cited by 3 · see citing works
Acute high glucose exposure impairs synaptosomal vesicle release activity
Alshakhshir, N., He, L., & Zhao, L. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149751 · Cited by 2 · see citing works
Nazareth, M., Duck, S. A., Fassinger, A., Elmore, G., Pinto, C., Nugent, M., Pierre, M. S., Lechner, C., Jantzie, L. L., Northington, F. J., et al. (2025) · Developmental Neuroscience · doi:10.1159/000548432 · Cited by 2 · see citing works
Iacono, D. (2025) · Neuroethics · doi:10.1007/s12152-025-09624-2 · Cited by 2 · see citing works
Mitochondria and Lipids in Cellular Signaling of the Brain: from Physiology to Neurodegeneration
Angelova, P. R., Millichap, L. E., & Abramov, A. Y. (2026) · Molecular and Cellular Biology · doi:10.1080/10985549.2025.2607428 · Cited by 2 · see citing works
Yuan, N. Y., Richards, W. D., Parham, K. T., Clark, S. G., & Lebakken, C. S. (2026) · Cells · doi:10.3390/cells15141266 · Cited by 2 · see citing works
Dhakne, P., Aher, D., Bhutada, R., & Sengupta, P. (2025) · Critical Reviews in Analytical Chemistry · doi:10.1080/10408347.2025.2545295 · Cited by 2 · see citing works
Genes, the brain, and artificial intelligence in evolution
Kamatani, N. (2020) · Journal of Human Genetics · doi:10.1038/s10038-020-0813-z · Cited by 2 · see citing works
Cakir, Z., Lord, S. J., Zhou, Y., Jang, G. Μ., Polacco, B. J., Eckhardt, M., Jimenez‐Morales, D., Newton, B. W., Orr, A. L., Johnson, J. R., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.06.495052 · Cited by 2 · see citing works
Self-citationMahley, R. W. (2025) · Springer eBooks · doi:10.1007/978-3-031-52641-1_2-1 · Cited by 1 · see citing works
Self-citationManolopoulos, A., Mustapić, M., Nogueras‐Ortiz, C. J., Delgado‐Peraza, F., Pucha, K. A., Yao, P. J., Blommer, J. M., Vreones, M. P., York, W., Knight, D. L., et al. (2025) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70143 · Cited by 2 · see citing works
Niño, S. A., Barrios-Camus, O., Silva-Pavez, E. E., Cárdenas, J. C., & González-Billault, C. E. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2026.168211 · Cited by 1 · see citing works
APOE4 exacerbates glucocorticoid stress hormone-induced tau pathology via mitochondrial dysfunction
Yu, Q., Du, F., Puerta-Alvarado, V., Goodman, J. H., & Waites, C. L. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08543-1 · Cited by 2 · see citing works
Cell-type-specific APOE4 cascade across the Alzheimer’s disease continuum
Shostak, D. M., Liang, Z., & Huang, Y. (2026) · Neuron · doi:10.1016/j.neuron.2026.04.024 · Cited by 1 · see citing works
APOE4 accelerates menopause-associated brain metabolic shift and disrupts bioenergetic adaptation
Wang, T., Shang, Y., McLean, J. W., Yin, F., & Brinton, R. D. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1796680
Xu, Y., Gunasekaran, T. I., Gu, Y., Reyes‐Dumeyer, D., Piriz, A. L., Sanchez, D. L., Mejía, D. R., Medrano, M. Z., Lantigua, R., Honig, L. S., et al. (2026) · The Lancet Neurology · doi:10.1016/s1474-4422(26)00313-3 · Cited by 1 · see citing works
E2F4 as a single multifactorial target against Alzheimer’s diseasePreprint
López‐Sánchez, N., Ramón‐Landreau, M., Trujillo, C., Garrido‐García, A., & Frade, J. M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.08.082784 · Cited by 1 · see citing works
Dammer, E. B., Afshar, S., Bian, S., Seyfried, N. T., Levey, A. I., Fortea, J., & Johnson, E. C. B. (2026) · medRxiv · doi:10.64898/2026.02.14.26346321 · Cited by 1 · see citing works
APOE4 disrupts the central dogma by arresting neuronal proteome dynamicsPreprint
Krogsaeter, E., McKetney, J., Li, L., Liu, I., Richards, A., Subramanyam, V., Yin, K., Gordon, M., Mairal, P. B., Stevenson, E. J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.15.738801 · Cited by 1 · see citing works
Self-citationMitochondria and Neurodegenerative Diseases
Johri, A., & Chandra, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11474-6
Zhu, Y., Luo, L., Zhou, L., Wu, Z., Yang, Y., Yu, W., Zhu, Z., Ran, X., & Wang, J. (2021) · Research Square · doi:10.21203/rs.3.rs-751697/v1
Serrano, E., Barrantes, F. J., & Valdivieso, Á. G. (2023) · Protein Expression and Purification · doi:10.1016/j.pep.2023.106312
Thorwald, M. A., Cacciottolo, M., Hou, X., Morgan, T. E., & Finch, C. E. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251386812
Crosstalk between ApoE-expressing cells and genotoxic stress in the mouse brain
Ayman, U., Otsuka, T., Dougnon, G., & Matsui, H. (2025) · Brain Research · doi:10.1016/j.brainres.2025.150080
Farmer, B. C., Williams, H. C., Devanney, N. A., Piron, M. A., Nation, G. K., Carter, D. J., Walsh, A. E., Khanal, R., Young, L. E. A., Kluemper, J. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16575414
Liang, T., Hang, W., Chen, J., Wu, Y., Wen, B., Xu, K., Ding, B., & Chen, J. (2021) · Figshare · doi:10.6084/m9.figshare.14175689
ApoE and Bioenergetic Signaling
Raffaı̈, R. L. (2026) · Springer eBooks · doi:10.1007/978-3-031-52641-1_70-1
ApoE and Bioenergetic Signaling
Raffaı̈, R. L. (2026) · Springer eBooks · doi:10.1007/978-3-031-96089-5_70
Mahley, R. W. (2026) · Springer eBooks · doi:10.1007/978-3-031-96089-5_2
Self-citationFrosina, M., Maurotti, S., Castagna, A., Montalcini, T., Pujia, A., & Tirinato, L. (2026) · MedComm · doi:10.1002/mco2.70789
Apolipoprotein E (ApoE): Structural insights, functionality, and genetic variability
Viswalingam, V., Kumar, D., Tewari, S., & Ganeshpurkar, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40563-1.00001-6
Apolipoprotein E in Alzheimer’s disease: Genetic predisposition and mechanistic implications
Koley, A., Aziz, N., Dash, B., Prakash, K. P., Firdaus, J. U., Atneriya, U. K., Wal, P., Kumar, A., & Ganeshpurkar, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40563-1.00004-1
- Authors
- Orr, A. L., Kim, C., Jimenez-Morales, D., Newton, B. W., Johnson, J. R., Krogan, N. J., Swaney, D. L., & Mahley, R. W.
- Affiliations
- Gladstone Institutes (US)
- Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA
- University of California, San Francisco (US)
- Corresponding author
- Mahley, Robert W.
- ORCID
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2019-04-08
- Volume
- 68
- Issue
- 3
- Pages
- 991-1011
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC6481541
- OpenAlex
- W2922380492
- Cited by
- 103
- References
- 124
- Citations by year
- 2026: 21 · 2025: 17 · 2024: 12 · 2023: 16 · 2022: 10 · 2021: 15 · 2020: 8 · 2019: 4
- FWCI
- 3.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- BrightFocus Foundation
- Gladstone Institutes
- National Institutes of Health
- National Institute on Aging (R56AG057932)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
- Keywords
- APOE ε4, Alzheimer's disease
- MeSH terms
- Adenosine Triphosphate, Animals, Energy Metabolism, Mitochondria, NAD, Neurons, Stress, Physiological, Reactive Oxygen Species, Proteome, Cell Line, Tumor, Mice, Apolipoprotein E4, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-11-02.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-11-02.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review